Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035062	maksa-1-is	u/l (u/l)	858	971	0.00%
3035062	afosmaksa1	u/l (u/l)	553	626	0.00%
3035062	s-afmaks1	u/l (—)	159	180	100.00%	Distribution not available
3035062	afosmaksa1	— (—)	142	149	100.00%	Distribution not available
3035062	s-maksa-1	u/l (u/l)	104	115	0.00%
3035062	s-maksa1	u/l (u/l)	70	70	0.00%
3035062	s-afos1ma	u/l (—)	67	76	100.00%	Distribution not available
3035062	maksa-1-is	— (—)	58	63	100.00%	Distribution not available
3035062	s-maksa-1-isoentsyymi	u/l (u/l)	21	21	0.00%	Distribution not available
3035062	maksa-1-ls	u/l (u/l)	18	22	0.00%
3035062	maksa-1-isoentsyymi	u/l (u/l)	14	14	0.00%
3035062	s-maksa-1	— (—)	6	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

314

501

6.26

182.29

1.2

1.1

100.12

85.96

u/l

1.20

300

440

Diseases of liver

337

655

5.23

163.09

1.2

1.1

107.55

80.62

u/l

5.11

303

598

Renal failure

383

737

4.65

155.53

1.2

1.1

103.56

85.86

u/l

1.99

364

648

All chronic kidney diseases

418

803

4.30

150.30

1.2

1.1

98.90

80.60

u/l

2.45

396

702

ILD medications: immunosuppressive drugs

440

1093

3.77

138.22

1.2

1.1

82.24

82.62

u/l

0.03

418

968

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

608

1337

3.16

133.63

1.2

1.1

98.32

78.50

u/l

4.28

561

1198

Anaemias

179

113

10.46

127.83

1.2

102.17

67.13

u/l

2.77

166

107

Other diseases of liver

206

330

6.38

122.68

1.2

1.1

104.58

80.45

u/l

2.80

182

301

Any gastric operation

384

430

4.50

120.26

1.2

1.1

86.53

66.63

u/l

3.83

355

367

GASTRO-related operations

384

430

4.50

120.26

1.2

1.1

86.53

66.63

u/l

3.83

355

367

Renal tubulo-interstitial diseases

547

1319

3.11

120.07

1.2

1.1

100.05

78.12

u/l

4.59

512

1173

Abnormal findings on examination of blood, without diagnosis

347

805

4.00

117.83

1.2

1.1

96.56

84.78

u/l

1.51

328

714

Autoimmune diseases excluding thyroid diseases, strict definition

560

965

3.20

116.31

1.1

83.49

82.17

u/l

0.14

525

863

Autoimmune diseases excluding thyroid diseases

575

1004

3.14

116.19

1.1

84.81

81.67

u/l

0.35

540

896

All kidney diseases

568

1343

2.91

108.62

1.2

1.1

95.90

77.53

u/l

3.78

535

1195

First line medication for Crohn's disease

596

1110

2.92

106.40

1.2

1.1

85.31

82.75

u/l

0.25

565

974

Other bacterial diseases

557

1300

2.90

105.38

1.2

1.1

98.80

78.46

u/l

4.33

515

1163

Autoimmune diseases related-to ILD

492

1494

2.83

95.58

1.1

80.82

85.14

u/l

0.49

460

1338

ILD medications

595

1187

2.73

94.84

1.1

86.63

82.69

u/l

0.44

560

1048

ILD medications: prednisolone, methylprednisolone, prednisone

580

1184

2.75

94.82

1.1

88.39

82.65

u/l

0.71

551

1046

Autoimmune diseases

565

1016

2.84

94.57

1.1

88.08

81.35

u/l

0.80

519

908

Other bacterial diseases

550

1305

2.69

89.44

1.2

1.1

97.24

77.82

u/l

3.99

508

1173

Bacterial infection, other or unspecified

340

896

3.32

86.76

1.2

1.1

104.72

78.89

u/l

3.23

315

792

Used for control exclusion in common control thyroid runs

513

913

2.85

86.28

1.1

87.57

81.56

u/l

0.62

474

820

Abnormal serum enzyme levels

225

517

4.29

85.57

1.2

1.1

98.83

90.51

u/l

0.57

216

464

Fever of other and unknown origin

338

926

3.27

84.98

1.2

1.1

104.98

81.44

u/l

2.72

320

837

Bacterial infection, other or unspecified

353

954

3.15

82.33

1.2

1.1

103.71

78.53

u/l

3.27

326

846

Other septicaemia

257

659

3.79

82.21

1.2

1.1

103.98

80.78

u/l

2.76

240

580

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

512

1281

2.61

79.70

1.2

1.1

85.31

82.18

u/l

0.33

464

1160

Insulin, fast-acting

243

645

3.80

79.05

1.2

1.1

110.60

80.70

u/l

2.66

225

578

Septicaemia

271

719

3.56

78.55

1.2

1.1

103.31

79.53

u/l

3.12

253

635

Inflammatory bowel disease treatment related agents

581

1311

2.49

78.48

1.1

85.95

82.80

u/l

0.34

546

1165

Fibrosis and cirrhosis of liver

102

124

8.48

78.08

1.1

121.96

71.61

u/l

6.27

115

Heart failure, not strict

430

1055

2.79

76.25

1.2

1.1

100.54

79.82

u/l

3.20

397

946

Insulin, fast-acting or short human

243

664

3.69

75.80

1.2

1.1

110.60

82.15

u/l

2.46

225

598

Acute renal failure

166

344

4.89

74.83

1.2

1.1

113.21

86.40

u/l

1.74

157

306

Explicit Sepsis

278

781

3.35

73.54

1.2

1.1

102.35

82.45

u/l

2.38

260

695

Aplastic and other anaemias

294

858

3.22

72.92

1.1

103.99

84.14

u/l

2.37

270

758

Oral corticosteroids

537

1300

2.46

72.18

1.1

87.75

83.15

u/l

0.52

504

1155

Disorders of gallbladder, biliary tract and pancreas

527

1358

2.46

71.87

1.2

1.1

94.57

80.15

u/l

2.58

476

1232

Implicit Sepsis

412

1152

2.71

71.67

1.1

97.23

81.01

u/l

1.98

374

1028

Bacterial Sepsis

289

764

3.26

71.44

1.2

1.1

104.95

82.09

u/l

2.27

266

672

Implicit bacterial Sepsis

263

690

3.41

70.44

1.2

1.1

108.52

83.57

u/l

2.23

240

606

Nonalcoholic fatty liver disease

108

159

6.95

69.92

1.2

1.1

89.11

77.36

u/l

0.86

150

Type 1 diabetes, wide definition, subgroup 1

149

299

5.03

69.62

1.2

1.1

115.03

77.50

u/l

2.22

136

276

L04AD Calcineurin inhibitors

113

176

6.56

69.33

1.3

1.1

94.38

84.20

u/l

0.44

108

167

Implicit bacterial Sepsis

277

745

3.24

67.96

1.2

1.1

107.11

82.66

u/l

2.34

252

654

Persons encountering health services in other circumstances

240

711

3.38

65.67

1.1

87.49

82.96

u/l

0.27

216

629

Malignant neoplasm of breast, HER2-negative

293

601

3.22

65.59

1.2

1.1

72.17

75.62

u/l

0.39

273

525

Malignant neoplasm of breast, HER-positive

244

549

3.50

65.57

1.2

1.1

72.11

75.88

u/l

0.38

231

477

Disorders of other endocrine glands

270

855

3.13

64.84

1.2

1.1

90.06

83.34

u/l

0.43

247

771

Malignant neoplasm of breast

293

606

3.18

64.37

1.2

1.1

72.17

75.78

u/l

0.42

273

530

Disorders of parathyroid gland

175

421

4.16

64.23

1.2

1.1

88.23

80.18

u/l

0.37

161

369

Type 1 diabetes

165

385

4.32

64.05

1.2

1.1

107.95

78.75

u/l

1.84

150

350

Osteopathies and chondropathies

331

1112

2.79

64.03

1.2

1.1

94.01

83.59

u/l

0.82

305

1002

L04AA Selective immunosuppressants

171

412

4.20

63.87

1.2

1.1

83.79

84.03

u/l

0.01

162

372

Type 1 diabetes, wide definition

150

328

4.62

63.27

1.2

1.1

115.73

77.34

u/l

2.33

137

302

Malignant neoplasm of breast, ER-positive, including Hilmo

244

555

3.43

63.27

1.2

1.1

72.11

75.84

u/l

0.38

231

482

Malignant neoplasm of breast, HER2-negative, including Hilmo

295

614

3.14

63.26

1.2

1.1

71.65

75.76

u/l

0.50

275

538

Malignant neoplasm of breast, including Hilmo

295

614

3.14

63.24

1.2

1.1

71.65

75.76

u/l

0.50

275

538

Insulin, intermediate and long-acting

308

1060

2.84

62.24

1.2

1.1

108.24

81.35

u/l

3.05

283

950

Insulin medication

335

1027

2.76

62.00

1.2

1.1

107.86

79.54

u/l

3.71

310

919

Insulin, combination of fast acting with intermediate-acting or long-acting

335

1131

2.72

61.61

1.2

1.1

107.86

80.99

u/l

3.40

310

1012

Second line medication for Crohn's disease

328

1226

2.69

60.16

1.2

1.1

77.43

84.54

u/l

0.84

313

1098

Malignant neoplasm

427

1012

2.51

59.72

1.2

1.1

85.59

82.71

u/l

0.24

399

896

Persons encountering health services for specific procedures and health care

516

1360

2.28

59.28

1.2

1.1

89.09

80.66

u/l

1.07

479

1220

Implicit Sepsis

417

1252

2.45

58.64

1.1

96.58

80.62

u/l

1.98

377

1123

Hyperparathyroidism

155

370

4.20

57.61

1.2

1.1

82.18

81.21

u/l

0.04

142

328

Diabetic maculopathy, excluding more controls

152

6.35

56.77

1.3

1.1

91.44

83.34

u/l

0.36

138

Hernia of abdominal wall, postoperative

165

6.05

56.68

1.2

1.1

98.05

67.09

u/l

1.42

135

L02BG Aromatase inhibitors

220

681

3.26

56.68

1.2

1.1

71.54

81.35

u/l

1.24

210

600

Presence of other functional implants

327

836

2.73

56.42

1.2

1.1

85.63

86.14

u/l

0.04

286

754

Osteoporosis

191

505

3.57

55.84

1.1

92.96

82.26

u/l

0.61

174

443

Malignant neoplasm, wide definition for exclusion

423

1026

2.43

55.27

1.2

1.1

84.60

82.43

u/l

0.18

395

910

IBD patients in KELA-register

151

370

4.12

55.16

1.1

73.33

88.53

u/l

0.96

146

333

Polyarthropathies

359

915

2.58

54.56

1.2

1.1

88.44

84.53

u/l

0.32

332

824

Noninfective enteritis and colitis

262

922

2.86

53.90

1.1

77.62

84.06

u/l

0.45

252

826

Reimbursement for rheumatic diseases

321

1250

2.57

53.81

1.1

85.75

84.61

u/l

0.10

295

1120

Condition for Implicit Sepsis (Organ dysfunction codes)

422

1277

2.34

53.63

1.1

96.37

80.55

u/l

2.00

384

1144

Other anaemias

253

829

2.92

53.60

1.1

107.68

84.69

u/l

2.53

233

732

Solid cancers, helper endpoint

410

1003

2.42

53.52

1.2

1.1

83.58

82.57

u/l

0.07

382

887

Other and unspecified anaemias

251

828

2.91

52.81

1.1

108.33

84.75

u/l

2.61

231

731

L04AX Other immunosuppressants

309

1204

2.58

52.21

1.2

1.1

77.50

84.31

u/l

0.74

295

1079

Medicines for HER+ breast cancer

245

800

2.93

51.98

1.2

1.1

72.00

82.36

u/l

1.51

232

709

Any reimbursement code in KELA

213

297

3.61

51.42

1.2

1.1

78.10

72.20

u/l

0.58

198

269

Any event in cancer register

427

1083

2.33

51.23

1.1

84.19

83.20

u/l

0.07

396

965

Inflammatory bowel disease, strict (require KELA)

151

392

3.89

50.99

1.1

73.33

88.10

u/l

0.94

146

353

Metabolic disorders

463

1270

2.23

50.87

1.2

1.1

92.37

79.94

u/l

1.81

421

1147

Abnormal results of function studies

141

6.22

50.24

1.2

1.1

108.19

80.56

u/l

1.60

129

Inflammatory bowel disease

190

580

3.30

50.21

1.1

74.21

84.13

u/l

0.74

184

524

Sub-endpoint used in defining T1D endpoints

173

489

3.51

50.06

1.2

1.1

112.12

82.31

u/l

1.90

157

449

Diseases of oesophagus, stomach and duodenum

497

1386

2.15

49.72

1.1

88.95

81.81

u/l

0.87

458

1253

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

346

1297

2.40

48.99

1.2

1.1

96.77

83.90

u/l

1.63

320

1157

Oxycodone

227

701

2.95

48.41

1.2

1.1

103.31

81.74

u/l

2.38

212

626

5-aminosalicylic acid

132

327

4.07

47.57

1.1

78.10

84.05

u/l

0.23

125

287

Cholangitis (primary sclerosing, PSC)

7.62

47.16

1.2

1.1

116.20

82.77

u/l

1.61

Persons encountering health services in other circumstances, wide

521

1283

2.10

46.98

1.2

1.1

85.37

83.87

u/l

0.13

492

1136

Persons encountering health services for other counselling and medical advice, not elsewhere classified

497

1276

2.12

46.96

1.2

1.1

83.39

83.89

u/l

0.04

474

1130

Condition for Implicit Sepsis (Organ dysfunction codes)

418

1303

2.22

46.78

1.1

96.51

79.80

u/l

2.16

380

1171

Oedema, not elsewhere classified

189

596

3.15

46.17

1.2

1.1

91.72

81.88

u/l

0.61

171

538

Complications of surgical and medical care, not elsewhere classified

468

1524

2.11

46.17

1.2

1.1

89.00

83.03

u/l

0.64

436

1365

Heart failure and antihypertensive medication

150

247

4.01

46.02

1.2

1.1

116.81

76.93

u/l

2.34

136

224

Cholelithiasis, broad definition with cholecystitis

416

1281

2.19

45.03

1.1

87.53

80.81

u/l

0.91

376

1157

Pneumonia, organism unspecified

423

1377

2.16

44.56

1.2

1.1

89.02

81.53

u/l

1.19

389

1236

Influenza and pneumonia

472

1442

2.09

44.53

1.2

1.1

89.60

80.81

u/l

1.57

434

1297

Diabetic retinopathy, strict definition

136

313

3.89

44.21

1.2

1.1

110.97

98.86

u/l

0.43

122

289

Pneumonias (Asthma/COPD co-morbidities)

453

1469

2.08

42.75

1.2

1.1

88.98

81.66

u/l

1.18

418

1321

Ulcerative colitis

145

415

3.52

42.51

1.2

1.1

74.77

86.46

u/l

0.66

140

375

All pneumoniae

454

1475

2.06

42.09

1.2

1.1

90.17

81.10

u/l

1.57

418

1326

General symptoms and signs

457

1085

2.12

41.94

1.1

91.37

80.72

u/l

1.14

412

980

Acute tubulo-interstitial nephritis

298

1080

2.39

41.72

1.2

1.1

87.42

79.36

u/l

1.03

273

958

Other disorders of fluid, electrolyte and acid-base balance

184

583

3.03

41.69

1.2

1.1

97.85

82.65

u/l

1.19

174

516

Ulcer of lower limb, not elsewhere classified

105

243

4.38

41.52

1.2

1.1

129.94

90.36

u/l

1.47

219

Hypertensive diseases (excluding secondary)

250

534

2.73

41.27

1.2

1.1

80.81

72.24

u/l

0.81

231

493

Hypertension, essential

361

899

2.28

41.01

1.2

1.1

88.26

77.65

u/l

1.09

328

824

Hypertensive diseases

365

911

2.27

40.96

1.2

1.1

83.72

77.83

u/l

0.65

331

836

Hypertension

365

911

2.27

40.94

1.2

1.1

83.72

77.83

u/l

0.65

331

836

Insulin, fast-acting (human)

183

4.86

39.67

1.3

1.1

123.01

77.10

u/l

1.66

169

Cholelithiasis

388

1266

2.12

38.92

1.2

1.1

81.89

80.69

u/l

0.12

352

1143

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

438

1482

2.02

38.69

1.2

1.1

88.96

81.92

u/l

1.15

405

1329

Certain infectious and parasitic diseases

415

980

2.13

38.62

1.1

90.87

78.34

u/l

1.62

381

881

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

408

1183

2.10

38.47

1.2

1.1

87.40

83.14

u/l

0.50

376

1063

408

1183

2.10

38.47

1.2

1.1

87.40

83.14

u/l

0.50

376

1063

Heart failure,strict

251

700

2.54

38.19

1.2

1.1

106.63

81.87

u/l

2.19

225

616

Hypothyroidism, levothyroxine purchases

102

116

4.99

38.13

1.2

109.78

67.24

u/l

1.58

109

Hypothyroidism and >3 levothyroxin purchases

102

116

4.99

38.13

1.2

109.78

67.24

u/l

1.58

109

Hypothyroidism (congenital or acquired)

102

117

4.95

37.75

1.2

109.78

67.24

u/l

1.58

110

Nutritional anaemias

257

1034

2.41

37.43

1.2

1.1

99.96

84.35

u/l

1.13

238

919

Gastro-oesophageal reflux disease

325

1285

2.19

37.17

1.1

87.66

82.67

u/l

0.38

301

1156

Liquid cancers, helper endpoint

187

579

2.83

36.97

1.1

113.30

81.13

u/l

3.33

174

508

Disorders of mineral metabolism

132

5.47

36.45

1.2

1.1

112.45

92.10

u/l

0.49

121

Finngen Rheumatological endpoints

405

1119

2.06

36.26

1.1

90.03

81.33

u/l

1.00

373

1015

Other disorders of skin and subcutaneous tissue, not elsewhere classified

100

248

4.08

36.14

1.2

1.1

98.47

83.87

u/l

0.73

220

Implicit viral Sepsis

156

517

3.04

36.05

1.2

1.1

104.87

82.48

u/l

1.44

147

461

Other disorders of skin and subcutaneous tissue

338

1422

2.12

35.83

1.2

1.1

97.53

82.21

u/l

1.69

311

1274

Other diseases of blood and blood-forming organs, wide

136

422

3.25

35.21

1.2

1.1

99.02

85.54

u/l

0.93

127

377

Hypothyroidism, strict autoimmune

298

866

2.27

35.00

1.2

1.1

86.97

81.01

u/l

0.44

262

775

Gout

147

418

3.12

34.43

1.1

102.46

91.45

u/l

0.47

134

367

Nausea and vomiting

144

461

3.08

33.98

1.2

1.1

107.53

82.46

u/l

1.23

134

418

Caries of dentine

126

371

3.33

33.71

1.2

1.1

97.84

89.57

u/l

0.31

120

337

Diabetes mellitus

442

1337

1.94

33.56

1.1

96.53

77.83

u/l

3.08

402

1209

Other retinal disorders

306

1106

2.17

33.32

1.2

1.1

102.15

83.58

u/l

1.83

274

990

General examination and investigation of persons without complaint and reported diagnosis

280

624

2.35

33.30

1.1

82.14

83.19

u/l

0.07

268

546

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

418

1285

1.97

33.30

1.1

99.15

78.35

u/l

3.31

378

1160

Diabetes, varying definitions

440

1337

1.94

33.29

1.1

96.46

77.86

u/l

3.04

401

1208

Iron deficiency anaemia

217

877

2.45

33.08

1.1

101.01

84.79

u/l

0.97

203

787

Complications of medical and surgical care

343

1552

2.04

33.06

1.1

93.68

82.52

u/l

1.05

327

1385

Gout, FINNGEN

147

498

2.96

32.58

1.1

102.46

92.24

u/l

0.42

134

441

Type 2 diabetes, wide definition

364

1150

2.03

32.28

1.1

106.17

78.87

u/l

4.10

337

1034

Erysipelas

308

1112

2.12

31.82

1.1

92.52

79.72

u/l

1.78

279

993

Osteoporosis with pathological fracture (FG)

123

5.30

31.74

1.2

1.1

112.32

85.53

u/l

0.59

106

Primary hyperparathyroidism

228

4.01

31.71

1.2

1.1

85.59

76.42

u/l

0.28

207

Disorders of calcium metabolism

6.00

31.70

1.2

1.1

120.76

79.35

u/l

0.99

Hypothyroidism, drug reimbursement

5.62

31.61

1.2

103.25

69.25

u/l

1.04

Diabetic maculopathy

226

3.93

31.39

1.3

1.1

91.73

103.29

u/l

0.47

207

Heart failure, strict

269

855

2.23

30.81

1.1

107.50

83.24

u/l

2.32

239

759

Dermatitis and eczema

463

1563

1.84

30.62

1.2

1.1

84.16

84.08

u/l

0.01

425

1407

Diseases of the skin and subcutaneous tissue

403

1033

1.96

30.53

1.1

86.94

82.44

u/l

0.42

370

923

Dental caries

132

419

3.05

30.52

1.2

1.1

96.61

89.17

u/l

0.29

126

380

Diabetes, insulin treatment (Kela reimbursement)

436

1408

1.88

30.38

1.1

97.85

79.33

u/l

2.92

395

1275

All-cause Heart Failure

265

844

2.23

30.29

1.2

1.1

107.67

83.52

u/l

2.25

235

751

Disorders of thyroid, IBD co-morbidities

152

4.19

30.22

1.2

1.1

78.65

75.85

u/l

0.12

137

Other heart diseases

205

533

2.52

30.21

1.2

1.1

97.32

72.31

u/l

2.13

191

490

Other medical care

218

838

2.35

29.82

1.2

1.1

95.19

84.52

u/l

0.73

200

745

Diseases of arteries, arterioles and capillaries (FINNGEN)

128

276

3.23

29.77

1.2

1.1

132.10

71.44

u/l

3.40

120

254

Abnormalities of breathing

369

1088

1.98

29.65

1.1

82.77

81.97

u/l

0.07

328

995

Disorders of choroid and retina

363

1331

1.94

29.20

1.2

1.1

100.01

83.16

u/l

1.89

326

1196

Other and unspecified iron deficiency

171

669

2.57

28.95

1.1

100.97

81.76

u/l

0.95

158

601

Complications of procedures, not elsewhere classified

350

1498

1.94

28.82

1.1

84.94

83.31

u/l

0.14

323

1340

Type 2 diabetes

417

1304

1.87

28.76

1.1

94.32

78.14

u/l

2.54

380

1179

Other heart diseases, wide

379

1209

1.92

28.53

1.2

1.1

94.71

77.45

u/l

2.22

341

1107

Endocrine, nutritional and metabolic diseases

288

677

2.16

28.14

1.2

1.1

79.67

75.69

u/l

0.32

262

618

Diabetic retinopathy, excluding more controls

151

294

2.90

27.53

1.2

1.1

109.79

84.64

u/l

1.47

137

261

Other noninfective gastroenteritis and colitis

128

443

2.91

27.50

1.2

1.1

77.35

86.88

u/l

0.46

122

393

Erysipelas

236

955

2.19

27.45

1.1

94.61

78.67

u/l

2.33

215

846

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

257

3.58

27.44

1.1

124.11

88.47

u/l

1.99

237

Peripheral artery operations in Hilmo

203

3.93

27.27

1.2

1.1

144.20

84.94

u/l

1.77

182

Bleeding

357

1336

1.91

27.15

1.2

1.1

92.42

84.37

u/l

0.84

325

1201

Diabetes medication

430

1406

1.82

27.15

1.1

98.16

78.06

u/l

3.21

392

1270

Other soft tissue disorders, not elsewhere classified

378

1174

1.89

26.94

1.2

1.1

82.86

84.90

u/l

0.17

352

1055

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

278

1357

2.03

26.92

1.1

95.03

82.91

u/l

0.98

266

1209

Tramadol

327

1021

1.97

26.62

1.1

94.64

78.69

u/l

1.90

295

924

Pain in limb

334

1158

1.94

26.23

1.2

1.1

79.26

85.08

u/l

0.59

308

1040

Infections, IBD-co-morbidities

138

4.06

25.43

1.1

103.89

78.36

u/l

1.08

126

Dermatitis

273

1366

2.00

25.40

1.2

1.1

87.50

84.09

u/l

0.25

250

1226

Disorders of lens

303

954

1.99

25.34

1.2

1.1

97.63

81.58

u/l

1.53

278

859

Cirrhosis of liver, NAS

5.70

25.27

1.1

141.12

74.64

u/l

3.30

Gout, unspecified

105

344

3.08

24.96

1.1

103.19

95.63

u/l

0.22

308

Constipation

380

1453

1.82

24.75

1.1

80.45

85.88

u/l

0.58

336

1315

Gout, strict definition

300

3.23

24.72

1.1

100.18

93.52

u/l

0.25

269

Other and unspecified dermatitis

233

1117

2.09

24.67

1.2

1.1

83.88

82.95

u/l

0.07

219

1007

Sleep apnoea

396

1430

1.80

24.64

1.1

80.93

86.91

u/l

0.83

355

1292

Diseases of the digestive system

206

943

2.18

24.24

1.2

1.1

99.55

84.82

u/l

0.96

186

844

Disorders of the thyroid gland

383

1386

1.80

24.16

1.1

87.49

83.17

u/l

0.32

345

1260

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

116

406

2.84

23.91

1.1

108.16

84.69

u/l

0.96

108

356

Other diseases of intestines

411

1321

1.77

23.80

1.1

87.37

83.91

u/l

0.29

373

1199

Gout, idiopatic and unspecified

122

446

2.75

23.80

1.1

103.99

91.94

u/l

0.46

110

399

Sleep apnoea, including avohilmo

409

1440

1.76

23.68

1.1

79.53

87.00

u/l

1.20

370

1300

Benzodiazepine use

408

1607

1.75

23.63

1.1

82.16

84.61

u/l

0.22

370

1451

Opioids

376

1069

1.83

23.62

1.2

1.1

89.34

78.28

u/l

1.32

339

967

Dyspnoea

372

1547

1.78

23.13

1.1

88.68

84.00

u/l

0.53

335

1404

Cardiovascular diseases (excluding rheumatic etc)

226

605

2.15

22.87

1.2

1.1

79.37

70.99

u/l

1.27

215

558

Gastrointestinal diseases

199

434

2.30

22.62

1.1

78.14

71.98

u/l

0.63

187

388

Chronic pancreatitis

180

3.81

22.60

1.1

115.72

87.71

u/l

0.94

164

Diarrhoea and gastroenteritis of presumed infectious origin

286

1361

1.90

22.59

1.2

1.1

93.13

81.20

u/l

1.28

260

1226

Hypothyroidism, other/unspecified

361

1327

1.79

22.45

1.1

87.78

82.99

u/l

0.35

321

1208

Systemic connective tissue disorders

169

741

2.29

22.44

1.1

87.86

82.62

u/l

0.40

158

662

Malaise and fatigue

210

796

2.13

22.39

1.1

94.97

83.60

u/l

0.94

190

721

Diabetic retinopathy

179

480

2.34

22.34

1.2

1.1

102.22

95.37

u/l

0.29

164

434

Biological medication for rheuma

289

3.14

22.19

1.1

69.46

82.12

u/l

0.91

270

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

257

1327

1.94

22.09

1.1

93.95

83.96

u/l

0.69

245

1186

Other diseases of biliary tract

132

4.29

21.80

1.3

1.2

108.76

77.08

u/l

2.06

119

Medical observation and evaluation for suspected diseases and conditions

250

624

2.05

21.77

1.2

1.1

88.60

83.19

u/l

0.35

232

546

Neoplasms

249

649

2.04

21.45

1.1

84.66

78.19

u/l

0.49

232

577

Vitreous haemorrhage

174

3.78

21.30

1.3

1.1

99.59

90.58

u/l

0.30

158

Vocal cord dysfunction

161

3.76

21.24

1.1

88.32

70.79

u/l

0.43

148

Postmenopausal osteoporosis with pathological fracture

111

4.58

21.04

1.2

1.1

123.88

70.62

u/l

1.14

Diseases of peritoneum

182

3.67

20.73

1.2

1.1

70.84

82.14

u/l

0.87

167

Codeine

348

1059

1.79

20.63

1.1

80.35

78.15

u/l

0.19

317

957

Symptoms and signs involving the digestive system and abdomen

378

1082

1.75

20.56

1.1

89.29

82.28

u/l

0.63

342

980

Hypo-osmolality and hyponatraemia

318

2.93

20.38

1.2

1.1

96.70

87.61

u/l

0.29

284

Infections of the skin and subcutaneous tissue

232

1187

1.94

20.01

1.2

1.1

96.49

82.71

u/l

0.95

212

1080

Intestinal infectious diseases

366

1634

1.70

19.67

1.1

97.57

81.11

u/l

1.97

333

1475

Hypothyreosis and Thyroxine purchase for inclusion criteria

367

1408

1.71

19.61

1.1

87.27

82.88

u/l

0.32

326

1280

Other diseases of pleura

196

836

2.06

19.61

1.1

106.99

84.67

u/l

2.52

174

739

Parasetamol

256

665

1.95

19.53

1.1

1.2

90.11

79.91

u/l

0.82

232

607

COPD/asthma related infections

400

1184

1.70

19.35

1.2

1.1

82.32

83.19

u/l

0.08

365

1064

COPD/asthma/ILD related infections

400

1184

1.70

19.35

1.2

1.1

82.32

83.19

u/l

0.08

365

1064

Cerebrovascular diseases (FINNGEN)

135

392

2.45

19.33

1.1

108.42

71.92

u/l

2.39

122

361

Exposure to unspecified factor

383

1655

1.67

18.92

1.1

95.44

81.40

u/l

1.58

335

1509

Obesity due to excess calories

197

984

2.01

18.81

1.1

79.99

83.71

u/l

0.36

182

895

Abnormal findings on diagnostic imaging of lung

204

991

1.98

18.56

1.2

1.1

98.85

83.21

u/l

1.42

191

881

Sulfasalazine

126

532

2.38

18.35

1.1

74.96

84.52

u/l

0.91

114

473

Intestinal infectious diseases

440

1560

1.61

18.25

1.1

93.33

81.47

u/l

1.48

398

1408

Other disorders of urethra and urinary system

297

1215

1.77

18.12

1.2

1.1

79.39

85.58

u/l

0.76

267

1114

Other cataract

190

707

2.04

18.01

1.2

1.1

101.62

83.35

u/l

1.23

174

632

Seropositive rheumatoid arthritis

116

477

2.44

17.77

1.1

80.06

85.17

u/l

0.38

105

426

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

118

226

2.63

17.65

1.1

1.2

81.87

69.88

u/l

0.94

111

208

Other diseases of pancreas

123

4.03

17.62

1.1

127.14

80.60

u/l

1.22

112

Cardiac arrhythmias

221

744

1.94

17.49

1.2

1.1

87.37

72.15

u/l

1.58

196

678

Heart failure and coronary heart disease

183

641

2.03

16.88

1.2

1.1

117.01

83.97

u/l

2.56

165

561

Abdominal and pelvic pain

360

1082

1.67

16.76

1.1

82.90

82.28

u/l

0.04

322

980

Spondyloarthritis

257

2.93

16.62

1.1

87.88

91.96

u/l

0.13

232

Rheumatoid arthritis

147

615

2.15

16.59

1.1

79.70

87.07

u/l

0.75

134

549

Antihypertensive medication - note that there are other indications

188

488

2.05

16.54

1.2

1.1

75.08

73.10

u/l

0.17

178

443

Certain infectious and parasitic diseases

268

741

1.82

16.45

1.2

1.1

85.98

82.12

u/l

0.24

249

669

Chronic apical periodontitis

419

1504

1.59

16.38

1.2

1.1

83.41

83.98

u/l

0.04

370

1373

Diseases of the ear and mastoid process

428

1352

1.59

16.38

1.1

86.34

82.75

u/l

0.37

399

1217

Cellulitis

390

2.53

16.29

1.2

1.1

105.99

82.75

u/l

1.05

351

Other functional intestinal disorders

191

918

1.94

16.29

1.1

78.50

86.55

u/l

0.56

173

827

Sleep disorders (combined)

421

1391

1.59

16.25

1.1

82.06

85.98

u/l

0.45

381

1254

Symptoms and signs involving the circulatory and respiratory systems

360

1090

1.66

16.16

1.1

82.59

81.90

u/l

0.05

325

997

Cholecystectomy

290

1471

1.71

16.11

1.1

81.55

86.62

u/l

0.58

265

1321

Other special examinations and investigations of persons without complaint or reported diagnosis

232

624

1.89

16.09

1.1

87.42

83.19

u/l

0.25

213

546

Depression medications

124

3.17

16.08

1.1

1.2

79.87

66.48

u/l

1.11

116

Atrial fibrillation and flutter

132

376

2.29

16.02

1.1

96.45

72.07

u/l

1.59

120

346

Other nutritional deficiencies

258

1391

1.75

15.99

1.1

80.71

83.52

u/l

0.30

238

1259

Hypothyroidism, strict autoimmune, 3 medication purchases required

326

1324

1.67

15.94

1.2

1.1

88.73

82.81

u/l

0.47

286

1203

Hyperlipidaemia, other/unspecified

158

710

2.06

15.93

1.2

1.1

90.95

81.47

u/l

0.51

139

629

Heart failure and bmi 25plus

153

487

2.13

15.86

1.1

105.30

79.26

u/l

1.75

139

437

Other diseases of the digestive system

136

632

2.16

15.84

1.2

1.1

99.19

91.05

u/l

0.35

124

564

Senile cataract

252

861

1.80

15.77

1.2

1.1

93.28

82.58

u/l

0.78

231

770

Ulcerative rectosigmoiditis

111

4.00

15.74

1.2

1.1

68.60

85.81

u/l

1.48

105

Pain in throat and chest

303

1071

1.70

15.67

1.1

84.49

82.23

u/l

0.15

275

980

Fall on same level

417

1450

1.57

15.50

1.2

1.1

91.59

80.64

u/l

1.40

369

1324

Hard cardiovascular diseases

330

1191

1.66

15.38

1.1

98.51

78.65

u/l

2.43

300

1085

Peripheral artery disease

184

759

1.94

15.29

1.2

1.1

115.24

84.23

u/l

2.20

171

665

Disorders of lipoprotein metabolism and other lipidaemias

310

1148

1.68

15.25

1.2

1.1

95.27

80.71

u/l

1.67

278

1036

Follow-up examination after treatment for conditions other than malignant neoplasms

169

556

2.02

15.18

1.2

1.1

73.56

82.60

u/l

1.27

155

483

Exclusions for E4_PCOS_BROAD

282

2.75

15.13

1.2

1.1

97.90

90.27

u/l

0.18

260

Diseases of arteries, arterioles and capillaries

258

1097

1.74

15.10

1.2

1.1

114.80

80.88

u/l

3.33

242

973

All influenza

102

430

2.38

15.00

1.2

1.1

93.16

86.34

u/l

0.35

382

Purpura and other haemorrhagic conditions

229

2.95

14.99

1.2

1.1

90.18

89.29

u/l

0.04

211

Valvular heart disease excluding rheumatic fever

183

685

1.94

14.90

1.1

106.53

78.58

u/l

2.57

166

615

Symptoms and signs involving the urinary system

294

1347

1.67

14.76

1.1

94.07

83.67

u/l

0.99

265

1216

Non-rheumatic valve diseases

182

682

1.93

14.75

1.1

105.22

78.64

u/l

2.39

165

614

Percutaneous Coronary Intervention

316

1175

1.65

14.72

1.1

99.24

80.69

u/l

2.05

290

1059

Other bacterial intestinal infections

308

2.61

14.30

1.1

92.22

84.29

u/l

0.32

274

Ischemic heart diseases

326

1206

1.63

14.26

1.1

96.84

80.59

u/l

1.84

300

1089

Obesity and other hyperalimentation

242

1360

1.72

14.17

1.1

80.96

83.27

u/l

0.24

225

1232

Other systemic involvement of connective tissue (FG)

108

475

2.25

13.98

1.1

88.91

82.35

u/l

0.36

422

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

161

511

1.99

13.92

1.2

1.1

85.23

72.91

u/l

1.49

152

472

Continuous positive airway pressure

239

2.69

13.89

1.1

1.2

83.78

76.24

u/l

0.52

215

Emergency coronary revascularization (for ACS)

334

1268

1.60

13.88

1.1

99.50

82.16

u/l

1.95

305

1142

Syncope and collapse

163

722

1.94

13.84

1.1

90.88

82.40

u/l

0.40

150

648

Obesity

240

1357

1.71

13.84

1.1

80.86

83.27

u/l

0.25

224

1229

Pain in joint

213

752

1.81

13.84

1.2

1.1

74.64

84.10

u/l

1.45

197

684

Mycoses

115

529

2.18

13.82

1.1

100.32

86.80

u/l

0.68

104

472

Coronary revascularization (ANGIO or CABG)

312

1175

1.63

13.80

1.1

98.66

80.69

u/l

1.93

286

1059

Fitting and adjustment of other devices

143

642

2.02

13.74

1.2

1.1

89.72

87.22

u/l

0.10

134

562

Diarrhoea and gastroenteritis of presumed infectious origin

369

1567

1.55

13.65

1.2

1.1

88.61

81.30

u/l

0.84

335

1413

Cholecystitis

225

2.86

13.63

1.1

115.58

82.14

u/l

1.23

203

Missing teeth due to accident, extraction or parodontitis

236

1302

1.71

13.61

1.1

82.82

86.32

u/l

0.22

206

1169

Dipeptidyl peptidase 4 (DPP-4) inhibitors

225

1034

1.75

13.58

1.1

90.78

84.44

u/l

0.44

205

926

Thrombocytopenia, unspecified

115

3.69

13.45

1.2

1.1

90.19

88.60

u/l

0.05

106

GI-bleeding

129

627

2.07

13.45

1.2

1.1

101.30

90.85

u/l

0.45

117

562

AV-block

255

2.62

13.37

1.1

102.25

85.78

u/l

1.02

231

Corns and callosities

4.02

13.35

1.4

1.1

107.84

86.21

u/l

0.33

Major coronary heart disease event

327

1239

1.60

13.30

1.1

98.33

80.67

u/l

2.01

300

1115

Gastroduodenal ulcer

106

479

2.22

13.23

1.1

107.60

90.90

u/l

0.96

424

Fracture of femur

116

491

2.15

13.22

1.1

108.49

85.71

u/l

0.80

439

Presence of cardiac and vascular implants and grafts

157

601

1.95

13.18

1.2

1.1

110.63

88.99

u/l

1.41

145

530

Non-ischemic cardiomyopathy

132

518

2.06

13.13

1.1

90.99

81.40

u/l

0.57

114

457

Atrial fibrillation and flutter with reimbursement

105

290

2.31

13.12

1.1

87.23

72.77

u/l

1.61

264

Cutaneous abscess, furuncle and carbuncle

103

464

2.23

13.06

1.2

1.1

95.97

81.93

u/l

0.57

421

Intracranial trauma

200

784

1.80

13.00

1.1

84.45

81.23

u/l

0.16

172

712

Other arthritis (FG)

121

583

2.08

12.94

1.1

94.40

84.37

u/l

0.44

114

526

Symptoms and signs concerning food and fluid intake

147

3.28

12.93

1.0

1.1

85.89

80.68

u/l

0.20

136

Psoriasis

120

577

2.09

12.91

1.1

79.69

85.95

u/l

0.31

108

521

Familial hypercholesterolemia, with ischemic heart disease

153

3.23

12.84

1.2

1.1

124.32

87.31

u/l

0.79

136

Injuries to the hip and thigh

184

924

1.81

12.78

1.2

1.1

104.73

85.33

u/l

1.04

162

827

Other antidepressants

372

1237

1.54

12.68

1.1

83.21

86.08

u/l

0.28

336

1128

Cough

160

810

1.87

12.55

1.1

74.10

84.92

u/l

1.24

146

735

Abnormal findings on diagnostic imaging of other body structures

253

2.67

12.52

1.1

94.84

79.86

u/l

0.50

224

Hypertensive heart and/or renal disease

107

364

2.20

12.45

1.2

1.1

100.36

79.59

u/l

1.28

324

420

1455

1.49

12.36

1.2

1.1

84.90

83.61

u/l

0.12

381

1309

Bacterial intestinal infections, IBD co-morbidities

344

2.40

12.30

1.1

100.96

84.33

u/l

0.62

307

Excluding asthma or asthma-COPD overlap

276

841

1.65

12.25

1.2

1.1

80.38

81.04

u/l

0.05

255

748

Unspecified urinary incontinence

184

2.96

12.24

1.1

80.04

76.91

u/l

0.14

170

Gonarthrosis [arthrosis of knee](FG)

271

964

1.64

12.18

1.1

85.02

84.66

u/l

0.02

243

872

Nerve, nerve root and plexus disorders

386

1576

1.50

12.11

1.2

1.1

87.42

83.33

u/l

0.39

361

1418

Fracture of lumbar spine and pelvis

421

2.24

12.08

1.2

1.1

88.71

87.86

u/l

0.03

375

Other pulmonary diagnosis

275

841

1.64

12.05

1.2

1.1

80.34

81.04

u/l

0.05

254

748

Pure hypercholesterolaemia

271

1092

1.62

12.05

1.1

104.71

81.12

u/l

2.34

245

983

Codeine or tramadol medication

404

1483

1.49

12.02

1.2

1.1

80.06

85.04

u/l

0.55

361

1339

Asthma, unspecified (mode), excluding more controls

178

738

1.81

12.00

1.1

77.77

77.69

u/l

0.01

165

661

Atherosclerosis, excluding cerebral and coronary sclerosis

165

710

1.85

11.98

1.2

1.1

120.87

84.44

u/l

2.44

153

619

Non-invasive ventilation

324

2.35

11.98

1.1

98.22

73.78

u/l

1.56

299

Diseases of the eye and adnexa

264

800

1.66

11.98

1.2

1.1

84.14

79.05

u/l

0.40

245

731

Gastric ulcer

324

2.42

11.97

1.1

111.44

89.08

u/l

1.07

284

Other diseases of urinary system

363

1346

1.52

11.77

1.1

81.98

85.35

u/l

0.35

319

1232

Episodal and paroxysmal disorders

381

1289

1.51

11.67

1.1

82.18

84.83

u/l

0.27

353

1159

Papulosquamous disorders

156

852

1.84

11.63

1.1

81.89

85.45

u/l

0.19

142

765

Rheumatoid arthritis, including avohilmo

157

860

1.83

11.60

1.1

82.58

85.04

u/l

0.20

144

771

Other specific joint derangements/joint disorders

243

953

1.65

11.55

1.2

1.1

79.71

82.92

u/l

0.30

227

861

Fentanyl

164

3.00

11.43

1.0

1.1

121.65

89.67

u/l

0.82

149

Vitamin B12 deficiency anaemia

170

2.96

11.38

1.2

1.1

82.86

87.08

u/l

0.16

155

Cardiovascular diseases

174

512

1.83

11.36

1.2

1.1

77.69

70.56

u/l

0.78

164

471

Viral infections characterized by skin and mucous membrane lesions

155

852

1.82

11.30

1.2

1.1

92.52

84.91

u/l

0.58

144

769

COPD differential diagnosis

271

843

1.61

11.15

1.2

1.1

80.02

81.39

u/l

0.11

250

750

ILD differential diagnosis

271

843

1.61

11.15

1.2

1.1

80.02

81.39

u/l

0.11

250

750

Other specified/unspecified arthritis

108

529

2.05

11.13

1.1

94.60

87.19

u/l

0.27

102

475

Acute pancreatitis

329

2.35

11.13

1.2

1.1

113.11

82.47

u/l

0.85

299

Other/unspecified seropositive rheumatoid arthritis

116

584

2.00

11.09

1.1

80.06

83.18

u/l

0.23

105

524

Viral infections characterized by skin and mucous membrane lesions

304

1701

1.53

11.06

1.2

1.1

85.44

83.57

u/l

0.18

280

1533

STROKE

209

841

1.69

11.06

1.1

102.15

76.57

u/l

2.31

193

760

Malignant neoplasm of prostate

246

2.27

11.06

1.2

1.1

67.63

94.95

u/l

3.05

219

Type 2 diabetes, definitions combined, including avohilmo

332

1272

1.52

11.03

1.1

90.35

80.09

u/l

1.27

306

1149

Asthma, excluding more controls

243

771

1.65

10.95

1.1

78.26

77.13

u/l

0.09

227

691

Other symptoms and signs involving the digestive system and abdomen

307

2.39

10.94

1.2

1.1

85.95

79.97

u/l

0.24

280

Sequelae of external causes of morbidity and mortality

105

513

2.06

10.91

1.2

1.1

93.69

85.98

u/l

0.31

100

452

Other reaction to severe stress, and adjustment disorders

134

714

1.88

10.83

1.2

1.1

100.81

78.57

u/l

1.26

129

651

Candidiasis

114

576

1.99

10.79

1.2

1.1

92.44

81.79

u/l

0.63

517

Thyrotoxicosis, other and/or unspecified

397

2.20

10.79

1.2

1.1

71.20

81.75

u/l

0.93

356

Recurrent or chronic depression

152

582

1.84

10.77

1.2

85.97

81.27

u/l

0.24

137

542

Zoster [herpes zoster]

372

2.24

10.75

1.2

1.1

92.21

83.94

u/l

0.37

334

Other bacterial intestinal infections

417

2.17

10.74

1.1

89.39

81.39

u/l

0.37

376

Smoking dependency

144

3.08

10.73

1.1

83.95

80.06

u/l

0.15

136

Seropositive rheumatoid arthritis, wide

116

592

1.97

10.69

1.1

80.06

83.37

u/l

0.25

105

532

Irritable bowel syndrome

109

544

2.01

10.69

1.1

74.18

83.14

u/l

0.74

492

Type 2 diabetes, definitions combined

328

1274

1.51

10.66

1.1

90.61

78.63

u/l

1.61

301

1150

Disorders of vitreous body and globe

207

1206

1.65

10.63

1.2

1.1

87.74

86.15

u/l

0.09

193

1078

Pain, not elsewhere classified

102

498

2.06

10.62

1.1

81.65

79.56

u/l

0.12

454

Familial hypercholesterolemia

263

2.49

10.61

1.2

1.1

124.63

85.30

u/l

1.08

236

Other diseases of anus and rectum

119

613

1.94

10.59

1.1

79.53

86.82

u/l

0.60

101

555

Intestinal stricture

125

657

1.91

10.56

1.2

1.1

106.95

85.79

u/l

1.01

118

586

Peripheral arterial reconstruction

294

2.39

10.54

1.2

1.1

132.87

88.33

u/l

1.35

261

Thyrotoxicosis with diffuse goitre

258

2.50

10.53

1.2

1.1

68.15

78.93

u/l

1.00

235

Other systemic involvement of connective tissue

111

561

1.99

10.52

1.1

90.30

83.30

u/l

0.40

100

498

Family history of malignant neoplasm

178

2.83

10.51

1.2

1.1

68.27

77.59

u/l

0.73

169

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

113

575

1.97

10.51

1.1

79.31

82.87

u/l

0.27

102

516

Other diseases of the respiratory system

396

2.18

10.44

1.1

102.49

89.74

u/l

0.50

354

Other respiratory disorders and diseases

396

2.18

10.44

1.1

102.49

89.74

u/l

0.50

354

Primary_lymphoid and hematopoietic malignant neoplasms

482

2.06

10.41

1.1

110.47

86.98

u/l

1.85

431

Mental and behavioural disorders due to tobacco

147

3.02

10.37

1.1

83.95

79.41

u/l

0.19

138

Disorders of vitreous body

202

1187

1.65

10.28

1.2

1.1

88.15

86.27

u/l

0.11

188

1059

malignant neoplasm of male genital organs

264

2.18

10.22

1.2

1.1

67.15

94.10

u/l

3.23

237

Anxiety disorders, excluding more controls

290

1233

1.53

10.20

1.2

1.1

90.70

80.73

u/l

0.81

269

1126

Falls/tendency to fall

373

1273

1.47

10.17

1.1

90.22

80.93

u/l

1.01

334

1168

Persons encountering health services for examination and investigation

209

624

1.68

10.16

1.1

88.81

83.19

u/l

0.34

196

546

Certain disorders involving the immune mechanism

362

2.22

10.15

1.1

100.33

84.51

u/l

0.82

332

Type 2 diabetes, strict (exclude DM1)

328

1289

1.50

10.12

1.1

90.61

80.10

u/l

1.30

301

1164

Any mental disorder

390

1348

1.45

9.98

1.1

89.29

81.77

u/l

0.71

350

1226

Diseases of the respiratory system

232

716

1.63

9.93

1.1

79.65

85.18

u/l

0.50

212

641

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

254

2.45

9.89

1.1

98.11

87.01

u/l

0.51

225

Headache

206

1009

1.63

9.87

1.1

82.29

80.24

u/l

0.13

183

916

Viral pneumonia

190

2.70

9.86

1.2

1.1

103.87

87.11

u/l

0.47

175

Chronic laryngitis and laryngotracheitis

273

2.40

9.82

1.2

1.1

96.20

84.99

u/l

0.26

251

Asthma, unspecified (mode)

179

796

1.70

9.81

1.1

78.36

82.06

u/l

0.32

166

707

Other (not insulin) diabetes medications

337

1356

1.48

9.79

1.1

89.68

78.90

u/l

1.43

308

1224

Other disorders of ear

328

1455

1.48

9.76

1.1

84.21

85.67

u/l

0.10

303

1309

Paralytic ileus and intestinal obstruction

103

521

1.98

9.75

1.2

1.1

107.55

87.84

u/l

0.71

467

Other respiratory diseases principally affecting the interstitium

350

2.21

9.69

1.2

1.1

89.97

86.45

u/l

0.13

316

Mood disorders, excluding more controls

329

1330

1.48

9.65

1.1

82.77

81.58

u/l

0.09

289

1211

Other symptoms and signs involving the nervous and musculoskeletal systems

157

912

1.73

9.59

1.1

81.63

83.68

u/l

0.09

147

823

Zoster [herpes zoster]

189

1135

1.64

9.58

1.2

1.1

85.85

84.07

u/l

0.13

173

1013

Asthma

250

833

1.58

9.54

1.1

79.01

81.29

u/l

0.19

233

741

Diseases of external ear

125

680

1.84

9.54

1.1

88.04

83.87

u/l

0.16

117

610

Concussion

163

775

1.72

9.53

1.1

84.51

81.32

u/l

0.14

141

703

Candidiasis

247

2.44

9.49

1.2

1.1

88.87

79.17

u/l

0.42

224

Alcoholic liver disease

155

2.86

9.47

1.0

1.1

112.44

93.69

u/l

0.41

143

Any death

231

1052

1.58

9.39

1.2

1.1

134.04

76.48

u/l

6.19

214

937

Thyrotoxicosis

106

550

1.94

9.37

1.1

71.02

84.03

u/l

1.39

494

Asthma (mode)

247

843

1.57

9.37

1.1

79.03

81.39

u/l

0.20

230

750

Malignant neoplasm of breast, HER-negative

374

2.14

9.34

1.1

77.51

73.11

u/l

0.30

323

Myocardial infarction

175

731

1.69

9.31

1.1

119.71

81.86

u/l

2.38

159

646

Leisure time condition

306

2.27

9.23

1.1

80.31

85.98

u/l

0.23

278

Arthropathies

291

976

1.51

9.22

1.2

1.1

81.08

82.87

u/l

0.14

272

882

Functional dyspepsia

103

534

1.94

9.14

1.1

81.54

81.58

u/l

0.00

483

Genitourinary diseases

165

476

1.74

9.11

1.1

85.10

82.79

u/l

0.10

151

432

Other diseases of stomach and duodenum

3.52

9.07

1.1

1.2

99.07

89.70

u/l

0.31

Supplementary factors related to causes of morbidity and mortality classified elsewhere

114

613

1.87

9.05

1.2

1.1

92.07

82.71

u/l

0.33

102

554

Statin medication

241

870

1.56

8.99

1.2

1.1

84.69

81.24

u/l

0.22

220

801

Asthma (only as main-diagnosis), excluding more controls

215

771

1.60

8.88

1.1

77.10

77.13

u/l

0.00

199

691

Other joint disorders

279

976

1.51

8.86

1.1

75.87

82.87

u/l

1.22

250

882

Interstitial lung disease

275

2.30

8.77

1.2

1.1

93.55

87.49

u/l

0.20

247

Interstitial lung disease endpoints

275

2.30

8.77

1.2

1.1

93.55

87.49

u/l

0.20

247

Neurological diseases

279

930

1.51

8.76

1.2

1.1

88.41

83.02

u/l

0.37

257

836

Haemorrhage from respiratory passages

122

608

1.81

8.74

1.1

90.48

86.14

u/l

0.29

106

545

Other interstitial pulmonary diseases

276

2.30

8.70

1.2

1.1

93.55

87.69

u/l

0.19

248

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

255

2.33

8.70

1.2

1.1

75.46

89.45

u/l

0.60

236

Unspecified haematuria

148

716

1.72

8.68

1.1

89.77

85.79

u/l

0.27

132

646

Psoriasis vulgaris

347

2.14

8.67

1.2

1.1

79.96

87.22

u/l

0.30

317

Depression

324

1523

1.44

8.66

1.1

82.53

83.59

u/l

0.07

284

1390

Acquired absence of limb

11.97

8.65

1.1

1.2

108.07

118.54

u/l

0.08

Secondary uncertain malignant neoplasm

210

2.49

8.60

1.2

1.1

128.47

82.37

u/l

1.81

185

Malignant neoplasm of prostate, including Hilmo

256

2.07

8.60

1.2

1.1

67.03

93.82

u/l

3.10

229

Exposure to other specified factors

255

1567

1.50

8.57

1.1

85.91

82.38

u/l

0.23

226

1429

Neurotic, stress-related and somatoform disorders

301

1445

1.46

8.57

1.2

1.1

91.36

81.58

u/l

0.82

280

1310

Covid-19 confirmed case

133

764

1.75

8.52

1.2

1.1

98.53

85.85

u/l

0.76

127

680

Low back pain

260

1254

1.49

8.29

1.1

74.24

85.61

u/l

2.58

230

1132

ILD, hospital admissions

270

2.27

8.25

1.2

1.1

92.29

88.21

u/l

0.12

242

Other CVD

375

2.06

8.19

1.1

101.39

86.48

u/l

0.39

340

Mood disorders

348

1599

1.41

8.14

1.1

83.03

83.77

u/l

0.05

306

1459

Anxiety disorders

302

1460

1.44

8.14

1.2

1.1

91.28

81.50

u/l

0.82

281

1323

Mood [affective] disorders

347

1597

1.41

8.12

1.1

83.11

83.79

u/l

0.05

305

1459

Acute upper respiratory infections

360

1583

1.40

8.11

1.2

1.1

82.64

84.45

u/l

0.18

328

1427

Benign neoplasm of colon, rectum, anus and anal canal

228

1309

1.52

8.11

1.1

91.81

85.73

u/l

0.56

207

1172

Coronary atherosclerosis

230

953

1.53

8.11

1.1

108.09

81.91

u/l

2.40

214

852

Depression or dysthymia

236

853

1.53

8.09

1.2

1.1

85.59

84.35

u/l

0.08

210

786

Congenital malformations, deformations and chromosomal abnormalities

190

1153

1.57

8.08

1.2

1.1

86.83

82.28

u/l

0.24

175

1053

Myocardial infarction, strict

161

694

1.66

8.06

1.1

121.25

82.68

u/l

2.27

145

614

Soft tissue disorders

329

1185

1.43

8.01

1.2

1.1

84.82

84.85

u/l

0.00

300

1065

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

319

2.14

7.99

1.2

1.1

134.61

86.97

u/l

1.38

279

Conduction disorders

104

454

1.86

7.99

1.1

93.44

81.94

u/l

0.93

407

Acute pancreatitis (for exclusion)

379

2.04

7.98

1.2

1.1

113.11

88.54

u/l

0.63

343

Malignant neoplasm of breast, ER-negative, including Hilmo

412

1.97

7.96

1.1

76.98

75.13

u/l

0.11

356

Pleural effusion

281

2.22

7.94

1.1

124.35

88.40

u/l

1.74

253

Periodontitis

336

1596

1.41

7.92

1.2

1.1

79.18

85.92

u/l

1.03

298

1448

Chronic periodontitis, including avohilmo

335

1595

1.41

7.89

1.1

79.10

85.95

u/l

1.05

297

1447

Diseases of pulp and periapical tissues, including avohilmo

349

1283

1.41

7.87

1.2

1.1

86.08

84.90

u/l

0.08

316

1168

Injuries to the abdomen, lower back, lumbar spine and pelvis

136

797

1.69

7.82

1.2

1.1

88.94

86.03

u/l

0.16

123

713

Coxarthrosis [arthrosis of hip](FG)

183

813

1.59

7.75

1.1

80.14

83.77

u/l

0.23

164

730

Myocardial infarction, without ST-elevation

142

776

1.67

7.71

1.2

1.1

123.11

86.49

u/l

2.04

129

687

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

244

2.27

7.71

1.2

1.1

75.60

87.89

u/l

0.48

226

Disorders of synovium and tendon

184

1029

1.57

7.70

1.1

95.23

84.72

u/l

0.54

167

925

Conductive and sensorineural hearing loss

278

1296

1.45

7.66

1.1

86.93

85.81

u/l

0.07

250

1165

Use of hypnotics and sedatives

363

1503

1.39

7.63

1.1

83.92

84.60

u/l

0.06

326

1362

Chronic gastritis

540

1.84

7.60

1.1

80.67

87.03

u/l

0.50

479

Bronchitis

359

1635

1.38

7.56

1.2

1.1

88.03

83.04

u/l

0.55

328

1475

Gonarthrosis

224

841

1.52

7.54

1.1

86.33

86.57

u/l

0.01

200

758

Type of accident

102

566

1.81

7.42

1.2

1.1

91.98

82.06

u/l

0.32

512

Ischaemic heart disease, wide definition

277

1191

1.44

7.36

1.2

1.1

106.96

80.83

u/l

2.65

255

1070

Weight loss

172

2.52

7.32

1.0

1.1

80.66

86.10

u/l

0.20

154

Internal derangement of knee

129

765

1.68

7.30

1.2

1.1

75.30

86.56

u/l

1.48

122

688

Alcohol use disorder, Swedish definition

176

1036

1.56

7.27

1.1

105.09

83.29

u/l

1.11

156

946

Acute bronchitis

139

829

1.65

7.25

1.2

1.1

88.81

84.10

u/l

0.29

125

744

Chronic lower respiratory diseases

401

1576

1.36

7.24

1.1

83.42

84.03

u/l

0.06

369

1426

Other CVD (FINNGEN)

140

2.50

7.19

1.2

1.1

103.05

74.73

u/l

0.51

127

Retention of urine

113

531

1.75

7.17

1.1

106.34

87.70

u/l

0.78

483

Sensorineural hearing loss

262

1232

1.45

7.17

1.1

89.11

86.35

u/l

0.17

236

1102

Other arrhythmias

212

1066

1.50

7.16

1.1

81.31

78.04

u/l

0.36

189

972

Major coronary heart disease event excluding revascularizations

205

900

1.52

7.16

1.1

115.67

80.86

u/l

2.70

188

801

Asthma (only as main-diagnosis)

217

833

1.51

7.15

1.1

76.97

81.29

u/l

0.40

201

741

Carbimazole or st.post thyroidectomy, condition for graves disease

437

1.91

7.14

1.1

68.26

79.74

u/l

1.49

397

Pain (limb, back, neck, head abdominally)

231

773

1.50

7.13

1.1

90.36

85.18

u/l

0.28

209

702

Diseases of the musculoskeletal system and connective tissue

155

473

1.65

7.12

1.1

74.96

83.77

u/l

0.94

145

424

Faecal incontinence

163

2.53

7.08

1.1

61.92

78.24

u/l

1.78

148

Failure and rejection of transplanted organs and tissues

7.15

7.05

1.2

1.1

132.69

92.65

u/l

0.44

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

263

2.18

7.03

1.2

1.1

74.51

81.53

u/l

0.44

251

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

466

1.86

7.01

1.2

1.1

74.01

81.84

u/l

0.75

428

Benign neoplasm: Colon

192

1212

1.52

7.00

1.2

1.1

93.72

84.52

u/l

0.86

179

1078

Gingivitis and periodontal diseases

347

1299

1.38

6.95

1.1

77.19

87.89

u/l

1.86

313

1178

Idiopathic gout

147

2.60

6.94

1.0

1.1

103.75

103.86

u/l

0.00

135

Gout due to impairment of renal function

8.50

6.88

1.2

73.79

108.71

u/l

0.59

Other gastritis (incl. Duodenitis)

416

1.91

6.81

1.1

107.94

86.50

u/l

0.66

371

Substance abuse, excluding more controls

177

984

1.54

6.78

1.1

102.87

81.50

u/l

1.34

156

903

Disorders of skin appendages

157

1002

1.57

6.75

1.1

82.48

83.42

u/l

0.04

152

905

Mycoses

279

1732

1.40

6.74

1.1

90.90

82.70

u/l

0.72

248

1570

Benign neoplasm of other and ill-defined parts of digestive system

369

1.96

6.74

1.1

89.88

87.76

u/l

0.11

330

Acute upper respiratory infections of multiple and unspecified sites

246

1271

1.44

6.64

1.2

1.1

84.87

83.26

u/l

0.12

227

1148

Benign neoplasms

305

1207

1.39

6.62

1.2

1.1

93.94

82.25

u/l

1.06

280

1095

Other diseases of oesophagus

139

2.60

6.61

1.1

1.2

114.20

98.55

u/l

0.18

129

L01XE Protein kinase inhibitors

3.12

6.59

1.2

1.1

151.42

83.69

u/l

1.78

Chronic myeloproliferative disease

8.87

6.59

1.2

1.1

160.87

115.20

u/l

0.64

Other or unspecified ileus, impaction or obstruction

331

2.00

6.56

1.3

1.1

90.03

87.77

u/l

0.06

295

Respiratory insufficiency

122

2.71

6.55

1.1

93.57

83.01

u/l

0.34

111

191

1125

1.50

6.55

1.1

105.14

82.76

u/l

1.29

170

1027

Other acute lower respiratory infections

169

1053

1.53

6.52

1.1

93.90

84.82

u/l

0.64

153

953

Other skin changes

374

1.93

6.49

1.2

1.1

119.58

86.77

u/l

0.94

332

Polycystic ovarian syndrome, consortium definition

246

1014

1.44

6.47

1.2

1.1

73.13

79.36

u/l

1.13

220

921

Infection of intervertebral disc (pyogenic)

7.55

6.45

1.1

134.36

119.79

u/l

0.12

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

121

735

1.65

6.44

1.1

84.66

82.09

u/l

0.09

109

667

Substance use, excluding alcohol

328

1.99

6.37

1.2

1.1

83.30

85.95

u/l

0.12

303

COPD (mode)

101

456

1.74

6.34

1.2

1.1

90.65

84.69

u/l

0.35

396

Examination and observation for other reasons

167

623

1.55

6.31

1.2

1.1

96.16

83.23

u/l

0.71

158

545

Diverticular disease of intestine

242

1080

1.43

6.31

1.2

1.1

77.19

86.08

u/l

1.12

215

975

Focal brain injury

3.10

6.31

1.1

1.0

111.86

78.91

u/l

0.68

Disorders of eyelid, lacrimal system and orbit

291

1603

1.38

6.31

1.1

79.99

85.03

u/l

0.63

263

1449

Abnormal spermatozoa

185

2.34

6.30

1.2

1.1

72.86

113.31

u/l

2.87

167

Injuries to the elbow and forearm

236

1458

1.42

6.28

1.2

1.1

77.30

84.68

u/l

0.97

205

1325

Congenital malformations, deformations and chromosomal abnormalities

202

1272

1.47

6.28

1.2

1.1

86.53

81.27

u/l

0.31

186

1155

Lower back pain or/and sciatica

345

1675

1.35

6.25

1.1

75.67

85.96

u/l

2.02

310

1517

Dental operations

199

683

1.50

6.24

1.1

84.80

86.41

u/l

0.10

186

624

Other disorders of lacrimal gland

130

812

1.61

6.21

1.1

78.94

83.90

u/l

0.35

117

733

Early onset COPD, excluding more controls

352

1.94

6.20

1.1

89.74

85.74

u/l

0.17

312

Adalimumab

144

2.51

6.18

1.1

74.15

80.26

u/l

0.20

138

Psychiatric diseases

329

1209

1.36

6.17

1.2

1.1

90.08

82.05

u/l

0.66

297

1102

Hypoglycaemia, other or unspecified

104

2.81

6.15

1.3

1.1

83.33

82.48

u/l

0.02

Diseases of oral cavity, salivary glands and jaws

195

670

1.50

6.14

1.1

76.71

89.99

u/l

1.94

181

609

Disorders of sclera, cornea, iris and ciliary body

181

1221

1.49

6.10

1.1

78.12

85.93

u/l

0.93

168

1102

Pulmonary heart disease, diseases of pulmonary circulation

112

677

1.66

6.09

1.1

97.68

85.49

u/l

0.85

103

600

Caries of dentine, including avohilmo

257

927

1.42

6.09

1.1

81.33

84.60

u/l

0.22

237

845

Disorders of myoneural junction and muscle in diseases classified elsewhere

10.34

6.08

1.0

1.2

119.36

61.10

u/l

1.92

Pacemaker

113

661

1.64

5.90

1.1

96.86

90.42

u/l

0.40

100

582

Mental and behavioural disorders due to psychoactive substance use

186

1177

1.47

5.85

1.1

102.34

82.71

u/l

1.26

164

1077

Hypertensive Heart Disease

339

1.83

5.84

1.2

1.1

102.97

80.19

u/l

1.04

301

Degeneration of macula and posterior pole

161

847

1.52

5.81

1.2

1.1

92.13

84.12

u/l

0.70

143

749

Poisoning by medicine

368

1.88

5.79

1.2

1.1

76.31

80.96

u/l

0.28

345

Cerebrovascular diseases

247

1243

1.40

5.76

1.1

103.53

84.00

u/l

1.66

218

1117

Stroke, excluding SAH

199

1006

1.45

5.64

1.1

109.45

83.20

u/l

1.98

170

902

Aortic valve malfunction, age under 60 years

151

2.40

5.62

1.2

1.1

124.28

91.86

u/l

0.52

145

Open wound of head

170

1110

1.48

5.62

1.1

93.87

82.68

u/l

1.11

147

1010

Coxarthrosis

168

741

1.50

5.61

1.1

81.76

85.33

u/l

0.21

151

664

Polyarthrosis

405

1.79

5.58

1.2

1.1

81.82

82.71

u/l

0.04

358

Benign neoplasm: Liver/bile ducts

3.86

5.55

1.1

97.44

89.57

u/l

0.18

Other diseases of hard tissues of teeth

189

664

1.47

5.55

1.1

84.69

89.87

u/l

0.28

176

604

Symptoms and signs involving the skin and subcutaneous tissue

233

1643

1.39

5.52

1.2

1.1

90.85

82.92

u/l

0.58

217

1475

Injuries to the head

355

1660

1.32

5.51

1.1

93.98

81.82

u/l

1.20

301

1521

Other abnormal uterine and vaginal bleeding

378

1.73

5.50

1.2

1.1

80.92

84.33

u/l

0.17

339

176

1089

1.46

5.48

1.1

102.00

83.90

u/l

1.05

156

995

Dental caries, including avohilmo

239

870

1.41

5.47

1.1

82.59

85.20

u/l

0.16

223

794

Infective dermatitis

178

2.26

5.47

1.1

119.95

89.15

u/l

0.52

163

Cystitis

283

1238

1.36

5.47

1.1

77.27

85.14

u/l

1.25

247

1135

Selective serotonin reuptake inhibitors

318

1239

1.34

5.46

1.1

78.39

86.18

u/l

1.04

282

1130

Hypotension

299

1.95

5.41

1.2

1.1

106.72

88.18

u/l

0.34

273

Presence of other devices

433

1.78

5.41

1.1

74.74

87.99

u/l

1.26

387

Abnormalities of heart beat

114

701

1.60

5.39

1.1

85.77

84.95

u/l

0.04

103

636

Stroke, including SAH

210

1075

1.42

5.39

1.1

106.34

84.20

u/l

1.66

183

969

Non-selective monoamine reuptake inhibitors

134

841

1.54

5.38

1.1

76.69

89.32

u/l

1.21

124

759

Disorders of lacrimal system

151

1010

1.49

5.31

1.1

78.38

84.02

u/l

0.50

138

908

Intracranial injury

185

1219

1.44

5.30

1.1

86.84

82.39

u/l

0.22

157

1108

Exclusions for E4_PCOS_CONSORTIUM

237

1069

1.39

5.29

1.2

1.1

78.90

81.99

u/l

0.19

220

968

Suicide or other Intentional self-harm

453

1.75

5.28

1.2

1.1

74.31

83.37

u/l

0.82

416

Symptoms and signs involving the nervous and musculoskeletal systems

190

1334

1.43

5.26

1.1

82.35

83.97

u/l

0.08

174

1197

Substance abuse

177

1152

1.45

5.24

1.1

102.87

83.09

u/l

1.19

156

1055

Infections with a predominantly sexual mode of transmission

536

1.68

5.22

1.2

1.1

104.97

76.66

u/l

1.19

500

Other infectious diseases

126

2.47

5.20

1.2

1.1

72.61

87.34

u/l

0.80

116

Contact with and exposure to communicable diseases

490

1.71

5.20

1.2

1.1

83.63

77.29

u/l

0.35

458

Isolated proteinuria with specified morphological lesion

7.50

5.17

1.2

1.1

90.45

83.27

u/l

0.09

Dysphagia

449

1.74

5.15

1.1

86.87

84.71

u/l

0.08

403

severe traumatic brain injury, does not include concussion

405

1.78

5.15

1.1

94.17

91.33

u/l

0.09

365

Fracture of rib(s), sternum and thoracic spine

585

1.65

5.14

1.1

95.92

89.22

u/l

0.17

525

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

315

1527

1.32

5.13

1.1

88.00

84.21

u/l

0.40

282

1391

Traumatic subdural haemorrhage

207

2.09

5.11

1.1

107.58

86.42

u/l

0.60

184

Malignant neoplasm of skin

149

681

1.50

5.10

1.2

1.1

85.00

83.74

u/l

0.07

134

595

Arthrosis

225

884

1.40

5.09

1.1

84.46

85.64

u/l

0.06

205

798

Biguanides

313

1444

1.32

5.07

1.1

87.53

83.76

u/l

0.32

284

1305

Psoriasis (vulgaris), strict definition

3.43

5.03

1.1

63.12

88.19

u/l

1.23

Acute sinusitis

159

1009

1.46

4.98

1.1

77.18

83.25

u/l

0.61

145

913

Viral and other specified intestinal infections

388

1.77

4.94

1.2

1.1

101.97

76.30

u/l

0.68

350

Benign neoplasm: Liver

3.70

4.94

1.1

97.00

90.56

u/l

0.13

Primary gonarthrosis, bilateral

182

1096

1.42

4.94

1.1

86.71

86.25

u/l

0.03

159

985

Diagnoses used for exclusion with ILD

508

1.68

4.92

1.1

98.33

86.64

u/l

0.57

459

Autoimmune hyperthyroidism

2.87

4.92

1.1

70.90

83.36

u/l

0.54

Myalgia

448

1.72

4.92

1.1

90.39

82.30

u/l

0.42

402

Disorders of conjunctiva

262

1569

1.34

4.91

1.2

1.1

78.46

84.67

u/l

0.76

247

1411

Otitis externa

412

1.75

4.88

1.2

1.1

92.83

83.98

u/l

0.22

374

Injuries to the thorax

142

958

1.48

4.87

1.2

1.1

89.43

85.73

u/l

0.13

130

859

Polymyalgia rheumatica

228

2.03

4.84

1.2

1.1

93.03

80.08

u/l

0.36

198

Pulmonary embolism

618

1.61

4.84

1.2

1.1

98.39

86.47

u/l

0.73

549

Left ventricular outflow tract obstruction (LVOTO), broad definition

162

2.23

4.84

1.2

1.1

124.28

89.54

u/l

0.58

154

Fibrosis of liver

9.28

4.82

1.3

1.2

113.67

83.71

u/l

—

Gonarthrosis, primary, with knee surgery

201

1149

1.40

4.80

1.1

84.16

85.23

u/l

0.08

178

1028

Infliximab

5.28

4.78

1.2

1.1

41.23

105.82

u/l

2.68

Pulmonary heart disease

621

1.60

4.75

1.2

1.1

98.39

86.80

u/l

0.70

552

Ischaemic Stroke, excluding all haemorrhages

182

956

1.42

4.75

1.1

107.17

83.75

u/l

1.56

154

858

Injuries to the ankle and foot

212

1372

1.37

4.73

1.2

1.1

90.06

80.40

u/l

0.62

185

1256

Superficial injury of hip and thigh

251

1.96

4.71

1.3

1.1

98.53

81.71

u/l

0.59

232

Gonarthrosis,primary

301

1413

1.31

4.70

1.1

84.57

85.11

u/l

0.04

269

1279

Dorsalgia

311

1271

1.31

4.69

1.1

78.87

85.52

u/l

0.79

281

1148

Other metabolic disorders

245

1.97

4.67

1.1

102.65

76.38

u/l

0.53

225

Spondylopathies

263

1175

1.34

4.66

1.2

1.1

81.86

87.09

u/l

0.35

234

1061

Barrett oesophagus

3.23

4.61

1.1

1.2

71.41

93.64

u/l

0.77

Other external causes of accidental injury

258

961

1.35

4.59

1.1

90.26

80.54

u/l

0.73

231

886

Malignant melanoma, including Hilmo

296

1.86

4.58

1.2

1.1

82.49

82.10

u/l

0.01

261

Fracture of forearm

184

1209

1.40

4.53

1.1

78.74

85.50

u/l

0.67

162

1092

Abnormal weight loss

154

2.22

4.52

1.0

1.1

87.32

86.18

u/l

0.03

139

Keratitis

113

740

1.53

4.52

1.1

80.68

86.32

u/l

0.47

104

666

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

536

1.63

4.52

1.2

1.1

74.01

81.45

u/l

0.73

496

Poisoning by drugs, medicaments and biological substances

415

1.72

4.50

1.2

1.1

76.79

81.49

u/l

0.30

385

Suppurative and unspecified otitis media

515

1.60

4.48

1.2

1.1

103.66

81.11

u/l

0.69

470

Polyp of the female genital tract

114

422

1.56

4.47

1.1

85.02

82.24

u/l

0.13

383

Atopic dermatitis, strict definition with reimbursement

474

1.65

4.46

1.2

1.1

71.81

79.82

u/l

0.68

435

External causes of morbidity and mortality

202

727

1.39

4.46

1.1

84.11

80.66

u/l

0.22

184

661

Urticaria and erythema

116

767

1.52

4.44

1.2

1.1

86.41

81.69

u/l

0.31

109

690

In situ neoplasms

127

857

1.49

4.42

1.1

80.27

83.64

u/l

0.27

119

764

Follow-up examination after treatment for malignant neoplasms

176

2.11

4.37

1.1

78.82

83.48

u/l

0.20

149

Persons with potential health hazards related to communicable diseases

104

668

1.55

4.37

1.2

1.1

82.83

79.76

u/l

0.18

616

Other diseases of upper respiratory tract

355

1452

1.28

4.34

1.1

77.62

86.15

u/l

1.15

319

1311

Adjustment and management of implanted device

303

1.82

4.28

1.0

1.1

91.39

91.95

u/l

0.02

266

Personality disorders, excluding more controls

414

1.69

4.26

1.2

1.1

90.90

82.22

u/l

0.19

382

Chronic periodontitis, complicated

178

1278

1.38

4.21

1.2

1.1

77.50

86.14

u/l

1.22

160

1158

199

2.02

4.21

1.3

1.1

128.73

79.07

u/l

0.79

182

Anxiety (asthma-related co-morbidities)

177

986

1.39

4.19

1.1

92.78

77.33

u/l

0.96

162

914

Postprocedural endocrine and metabolic disorders, not elsewhere classified

227

1.95

4.19

1.1

106.00

76.37

u/l

0.55

211

Other (seronegative) rheumatoid arthritis, wide

394

1.71

4.19

1.1

78.95

85.13

u/l

0.39

352

Nail disorders

140

2.23

4.17

1.1

119.58

81.18

u/l

0.59

133

Malignant neoplasm of digestive organs

106

547

1.53

4.16

1.1

95.06

84.21

u/l

0.56

101

480

Malignant melanoma

256

1.88

4.15

1.3

1.1

83.42

84.19

u/l

0.02

223

Diseases of pulp and periapical tissues and dental caries

205

769

1.37

4.09

1.1

78.98

85.74

u/l

0.65

189

701

Other hearing loss

531

1.59

4.08

1.2

1.1

100.31

89.14

u/l

0.33

468

Myocardial infarction, unclassifiable

353

1.70

4.06

1.1

124.93

90.97

u/l

0.91

314

All anxiety disorders

180

1034

1.38

4.06

1.2

1.1

91.77

78.32

u/l

0.80

165

943

Somatoform disorder

294

1.81

4.05

1.1

77.10

76.72

u/l

0.01

269

Dermatophytosis

237

1.91

4.05

1.1

87.64

88.65

u/l

0.02

217

Unspecified contracted kidney

10.29

4.04

1.0

1.3

163.57

91.30

u/l

—

Hernia of abdominal wall

140

982

1.43

4.02

1.2

1.1

92.97

85.88

u/l

0.30

130

881

Symptoms and signs involving cognition, perception, emotional state and behaviour

304

1622

1.28

4.01

1.1

88.32

83.61

u/l

0.32

271

1468

Disease of hard tissues of teeth, NOS

174

652

1.40

4.00

1.2

1.1

81.47

89.44

u/l

0.47

156

592

Other neurological diseases

231

1375

1.32

3.99

1.1

87.59

86.01

u/l

0.08

212

1231

L02BB Anti-androgens

144

2.16

3.92

1.3

1.1

68.69

110.41

u/l

1.92

131

Sequelae of cerebrovascular disease

113

658

1.48

3.89

1.1

97.87

85.94

u/l

0.61

103

586

Colectomy operation

328

1.74

3.88

1.2

1.1

92.00

88.45

u/l

0.10

296

Undetermined asthma, excluding more controls

213

1.93

3.84

1.1

69.22

80.83

u/l

0.63

192

Trichomoniasis

6.16

3.84

1.2

1.1

78.56

66.07

u/l

—

Trichomoniasis

6.13

3.84

1.2

1.1

78.56

66.07

u/l

—

Venous thromboembolism

171

1212

1.36

3.78

1.2

1.1

89.62

85.37

u/l

0.31

159

1083

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

462

1.61

3.77

1.1

82.40

81.38

u/l

0.05

427

Calcific aortic valvular stenosis, including rheumatic fever

583

1.53

3.75

1.1

108.24

91.50

u/l

0.61

517

Other and unspecified nail disorders

3.63

3.71

1.0

1.2

80.93

91.82

u/l

0.26

Benign paroxysmal vertigo

653

1.50

3.70

1.1

81.64

84.99

u/l

0.17

583

Operations 2 for CAVS

578

1.53

3.70

1.1

108.77

91.78

u/l

0.61

512

Calcific aortic valvular stenosis, diagnosis (helper)

578

1.53

3.70

1.1

108.77

91.78

u/l

0.61

512

Adenocarcinoma and Papillary adenocarcinoma of kidney

6.78

3.69

1.4

1.3

246.88

115.34

u/l

—

Superficial injury of ankle and foot

175

2.01

3.67

1.2

1.1

83.95

76.63

u/l

0.24

165

Calcific aortic valvular stenosis

580

1.52

3.64

1.1

108.77

91.63

u/l

0.62

514

Calcific aortic valvular stenosis, operated

580

1.52

3.64

1.1

108.77

91.63

u/l

0.62

514

Shoulder lesions

233

1082

1.31

3.59

1.2

1.1

83.86

86.57

u/l

0.16

217

971

Accidents

249

961

1.30

3.57

1.1

90.90

80.54

u/l

0.77

225

886

Undetermined asthma

219

1.88

3.57

1.1

69.22

90.08

u/l

1.14

195

Injuries to the knee and lower leg

366

1645

1.24

3.54

1.1

90.62

82.19

u/l

0.98

333

1486

Superficial injury of lower leg

476

1.58

3.54

1.1

102.86

83.69

u/l

0.99

425

Unspecific neurodegenerative disorder

694

0.62

3.53

1.0

1.1

84.02

88.39

u/l

0.23

602

Benign neoplasm: Caecum

199

1.92

3.52

1.2

1.1

99.22

87.45

u/l

0.30

179

Disorders of iron metabolism

4.29

3.52

1.3

1.2

87.05

90.07

u/l

0.05

Inflammatory diseases of female pelvic organs

195

1080

1.33

3.52

1.1

75.18

78.32

u/l

0.37

167

985

Bacterial, viral and other infectious agents

131

2.15

3.51

1.3

1.1

123.48

80.33

u/l

1.07

125

Alzheimer disease, including avohilmo

599

0.59

3.50

1.0

1.1

99.65

88.30

u/l

0.44

517

Alzheimer disease

517

0.55

3.46

1.1

102.18

89.80

u/l

0.39

452

DVT of lower extremities and pulmonary embolism

131

933

1.40

3.43

1.2

1.1

92.44

87.42

u/l

0.31

123

831

Benign neoplasm: Colon, unspecified

520

1.54

3.42

1.1

105.56

88.32

u/l

0.84

462

Other malignant neoplasms of skin (=non-melanoma skin cancer)

128

620

1.42

3.41

1.2

1.1

86.10

84.32

u/l

0.09

116

541

Glucagon-like peptide-1 (GLP-1) analogues

601

1.50

3.40

1.1

1.2

79.64

85.45

u/l

0.42

548

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

601

1.50

3.40

1.1

1.2

79.64

85.45

u/l

0.42

548

Excessive earwax

168

1223

1.34

3.39

1.1

82.37

84.92

u/l

0.12

150

1094

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

136

660

1.40

3.37

1.2

1.1

83.91

84.48

u/l

0.03

123

575

Paralytic ileus

2.85

3.36

1.3

1.1

98.27

95.12

u/l

0.05

Ventral hernia

499

1.55

3.34

1.2

1.1

87.66

85.82

u/l

0.06

443

Degenerative diseases of the nervous system

597

0.59

3.33

1.0

1.1

100.12

90.11

u/l

0.35

521

Fracture of foot, except ankle

468

1.56

3.32

1.2

1.1

83.23

78.26

u/l

0.30

429

Factitial dermatitis

8.80

3.28

1.2

1.1

97.50

74.86

u/l

—

Common variable immunodeficiency

8.76

3.28

1.5

1.1

197.33

50.16

u/l

—

547

1.48

3.27

1.2

1.1

93.22

88.26

u/l

0.23

480

Open wound of wrist and hand

121

843

1.40

3.25

1.1

88.87

87.27

u/l

0.06

108

771

Pain associated with micturition

205

1.86

3.24

1.3

1.1

66.87

80.15

u/l

0.98

188

Primary coxarthrosis, bilateral

632

1.47

3.24

1.2

1.1

78.63

88.06

u/l

0.44

559

Diseases of middle ear and mastoid

155

938

1.35

3.24

1.1

97.03

82.67

u/l

0.67

145

851

Basal cell carcinoma

122

598

1.41

3.23

1.2

1.1

83.90

83.04

u/l

0.04

113

520

Duodenal ulcer

170

1.95

3.23

1.1

87.70

97.88

u/l

0.36

154

Asthma-related pneumonia

110

772

1.42

3.20

1.1

84.65

86.10

u/l

0.08

104

685

Disorder of pancreatic internal secretion, other and/or unspecified

6.50

3.20

1.0

1.2

128.14

54.65

u/l

—

Vitamin D deficiency

4.21

3.20

1.2

1.1

118.30

73.66

u/l

—

Excessive attrition of teeth

165

1242

1.33

3.17

1.1

77.53

83.89

u/l

0.69

147

1134

Asthma-related pneumonia or sepsis

110

774

1.42

3.16

1.1

84.65

86.14

u/l

0.08

104

687

Asthma, hospital admissions 3, pneumonia

110

774

1.42

3.16

1.1

84.65

86.14

u/l

0.08

104

687

Open wound of forearm

137

2.05

3.16

1.3

1.1

78.83

86.62

u/l

0.32

123

Asthma-related infections

175

1302

1.32

3.14

1.1

82.93

86.02

u/l

0.23

163

1165

Asthma, hospital admission 2, infections

175

1302

1.32

3.14

1.1

82.93

86.02

u/l

0.23

163

1165

Mental and behavioural disorders due to alcohol

141

998

1.36

3.12

1.1

107.27

83.66

u/l

1.14

124

915

Artificial joint operation, meniscal resection

289

1510

1.24

3.10

1.1

79.24

86.68

u/l

1.18

254

1369

Other headache syndromes

125

904

1.38

3.10

1.2

1.1

75.98

82.17

u/l

0.56

119

811

Dorsopathies

311

1277

1.24

3.09

1.2

1.1

82.51

85.37

u/l

0.23

284

1154

Haemorrhoids and perianal venous thrombosis

670

1.45

3.09

1.2

1.1

93.98

87.46

u/l

0.37

600

Microscopic polyangiitis

7.68

3.07

1.5

1.1

56.00

85.00

u/l

—

Other bacterial agents as the cause of diseases classified to other chapters

5.08

3.06

1.4

1.1

99.75

105.88

u/l

—

Benign intracranial hypertension

7.59

3.06

1.2

1.0

71.00

76.39

u/l

—

Diseases of inner ear

172

1266

1.32

3.06

1.1

81.51

86.83

u/l

0.40

159

1131

Disorders of vestibular function (Vertigo)

149

1093

1.34

3.06

1.1

83.95

86.05

u/l

0.12

138

978

Bipolar affective disorders

307

1.66

3.02

1.2

1.1

100.02

80.41

u/l

0.39

287

Specific personality disorders

401

1.57

2.99

1.2

1.1

91.71

80.17

u/l

0.23

373

Malignant neoplasm of penis, including Hilmo

10.18

2.99

1.0

1.2

52.80

204.40

u/l

—

Other viral diseases, not elsewhere classified

292

1.68

2.99

1.1

75.35

87.85

u/l

0.68

268

Diseases of spleen

3.89

2.99

1.1

1.2

91.80

94.31

u/l

—

Car occupant injured in other and unspecified transport accidents

309

1.65

2.96

1.2

1.1

88.33

82.23

u/l

0.21

286

Striking against or struck by other objects

587

1.47

2.95

1.2

1.1

95.61

85.68

u/l

0.44

536

Other and unspecified disorders of vitreous body

138

1010

1.35

2.94

1.2

1.1

83.09

86.47

u/l

0.18

128

901

Benign neoplasm: Descending colon

114

2.12

2.94

1.3

1.1

98.38

89.98

u/l

0.24

102

Other extrapyramidal and movement disorders in other diseases

507

1.50

2.94

1.1

70.79

85.04

u/l

1.97

455

Atopic dermatitis

157

970

1.33

2.94

1.2

1.1

72.04

81.64

u/l

1.48

146

879

Artrosis, including avohilmo

254

1108

1.26

2.91

1.1

79.97

87.64

u/l

0.92

230

1011

Injuries to the wrist and hand

298

1683

1.23

2.89

1.1

86.06

82.94

u/l

0.22

269

1524

Basal cell carcinoma, including avohilmo

126

632

1.38

2.89

1.2

1.1

80.34

83.86

u/l

0.21

116

549

Gastrojejunal ulcer

6.73

2.87

1.2

156.67

108.77

u/l

—

Disorder of lipoprotein metabolism, unspecified

229

1.75

2.86

1.1

89.24

88.76

u/l

0.01

206

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

297

1.65

2.85

1.2

78.17

72.10

u/l

0.45

276

Myelodysplastic syndrome, including Hilmo

3.18

2.85

1.1

146.83

91.70

u/l

0.54

Obesity related asthma

105

750

1.40

2.85

1.1

75.73

86.61

u/l

1.29

674

Fall on same level involving ice and snow

173

1335

1.30

2.83

1.1

93.52

85.07

u/l

0.44

151

1212

Other inflammation of eyelid

260

1.70

2.82

1.2

1.1

67.33

82.88

u/l

1.34

237

Otitis media, unspecified

125

1.99

2.82

1.1

84.22

75.72

u/l

0.29

115

Unspecified fall

145

1076

1.33

2.82

1.2

1.1

94.13

85.72

u/l

0.40

133

970

Granulomatous disorders of skin and subcutaneous tissue

3.36

2.81

1.1

75.82

92.27

u/l

0.42

Other specified/unspecified necrotizing vasculopathies

4.50

2.80

1.1

67.13

100.89

u/l

—

Acute nephritic syndrome

3.60

2.79

1.1

70.15

97.99

u/l

—

Hyperplasia of prostate

355

1.46

2.79

1.1

1.2

74.60

98.55

u/l

2.60

325

Chronic hepatitis NAS

3.97

2.78

1.1

129.33

93.22

u/l

—

Other/unspecified synovitis and tenosynovitis

202

1.79

2.76

1.1

122.32

88.00

u/l

0.49

186

Polycythaemia vera

2.73

2.72

1.0

1.1

97.38

85.55

u/l

0.23

125

849

1.35

2.70

1.2

1.1

84.31

86.42

u/l

0.11

115

745

Infections with a predominantly sexual mode of transmission

100

666

1.40

2.69

1.2

1.1

101.75

75.50

u/l

1.22

619

Actinic keratosis

116

789

1.36

2.66

1.2

1.1

87.10

85.29

u/l

0.09

106

691

Epilepsy

592

1.43

2.64

1.2

1.1

89.32

86.63

u/l

0.11

526

Personality disorders

471

1.49

2.63

1.2

1.1

90.90

80.57

u/l

0.24

441

Glaucoma

177

1189

1.28

2.62

1.2

1.1

77.78

87.92

u/l

1.48

149

1073

Hypertrophy of breast

391

1.54

2.62

1.1

67.59

76.81

u/l

1.57

357

Corticotropin deficiency

4.75

2.61

1.1

233.43

112.20

u/l

—

Acquired haemolytic anaemia

3.36

2.60

1.1

103.20

91.70

u/l

—

Other bacterial agents as the cause of diseases classified to other chapters

4.05

2.58

1.4

1.1

99.75

101.16

u/l

—

Other diseases of lip and oral mucosa

122

910

1.34

2.58

1.2

1.1

79.60

84.05

u/l

0.38

105

823

Other and unspecified trigeminal disorders

4.04

2.57

1.4

1.3

66.38

69.95

u/l

—

Early onset COPD

458

1.49

2.56

1.1

89.74

91.50

u/l

0.07

417

Cystic disease of liver

5.56

2.56

1.5

1.1

108.43

80.45

u/l

—

Other bursopathies

245

1.68

2.55

1.3

1.1

71.18

84.77

u/l

0.82

219

Carcinoid syndrome

5.53

2.55

1.2

224.17

127.92

u/l

—

Severe visual impairment, monocular

5.53

2.55

1.0

1.1

80.10

113.74

u/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.53

2.55

1.0

1.2

85.17

60.73

u/l

—

Provisional assignment of new diseases of uncertain etiology

152

1170

1.30

2.54

1.2

1.1

96.14

83.44

u/l

0.92

145

1047

COPD

133

820

1.33

2.54

1.2

1.1

95.42

87.89

u/l

0.45

117

727

Temporomandibular joint disorders, including avohilmo

124

916

1.34

2.54

1.2

1.1

86.23

79.32

u/l

0.39

107

838

Mental and behavioural disorders due to alcohol, excluding acute intoxication

120

891

1.34

2.53

1.1

105.13

84.79

u/l

0.76

104

815

Dental pulpitis, including avohilmo

266

1413

1.22

2.52

1.1

78.36

83.37

u/l

0.65

240

1290

Fracture of lower leg, including ankle

166

1283

1.28

2.52

1.1

97.52

83.60

u/l

0.81

147

1155

123

915

1.33

2.51

1.1

79.87

84.20

u/l

0.29

113

823

Hypertrophy of breast in women and men

436

1.49

2.50

1.1

70.00

80.17

u/l

1.56

400

Codes for special purposes

152

1173

1.30

2.50

1.2

1.1

96.14

83.41

u/l

0.92

145

1048

Carpal tunnel syndrome

189

1321

1.26

2.50

1.1

89.65

83.64

u/l

0.35

172

1191

Menorrhagia

110

444

1.38

2.49

1.2

1.1

72.23

81.01

u/l

1.08

102

403

Amyloidosis, other/unspecified

3.49

2.49

1.3

1.1

77.89

89.73

u/l

—

Disorders of breast

154

1083

1.29

2.47

1.1

71.72

79.39

u/l

1.37

140

979

Wet age-related macular degeneration

323

1.56

2.46

1.1

87.52

90.76

u/l

0.13

286

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

116

1.99

2.45

1.1

66.24

78.14

u/l

0.64

109

Restless leg syndrome

248

1.66

2.45

1.0

1.1

70.67

79.16

u/l

0.65

231

Other renal tubulo-interstitial diseases

3.15

2.44

1.1

88.50

80.78

u/l

—

Delirium, not induced by alcohol and other psychoactive substances

203

1.73

2.42

1.2

1.1

71.89

90.43

u/l

1.15

184

Urolithiasis

647

1.39

2.41

1.1

81.91

90.24

u/l

0.60

586

Other dorsopathies, not elsewhere classified

294

1274

1.21

2.41

1.2

1.1

80.75

85.51

u/l

0.47

271

1151

Other viral diseases

512

1.44

2.41

1.1

78.97

83.38

u/l

0.23

466

390

1.50

2.41

1.2

1.1

99.62

88.03

u/l

0.46

346

Alcoholic gastritis

5.04

2.40

1.2

1.5

64.22

95.50

u/l

—

Skin changes due to chronic exposure to nonionizing radiation

118

816

1.34

2.40

1.2

1.1

86.26

86.46

u/l

0.01

108

716

Melanocytic naevi, other sites/unspecified

124

1.94

2.40

1.3

1.1

64.63

81.95

u/l

0.79

117

Conjunctivitis

216

1459

1.24

2.40

1.2

1.1

80.14

83.85

u/l

0.32

204

1314

Corneal ulcer

328

1.56

2.39

1.2

1.1

83.87

89.41

u/l

0.26

301

Hydrocephalus in other diseases

6.37

2.38

1.0

1.1

114.40

49.63

u/l

—

Explicit fungal Sepsis

6.35

2.38

1.0

146.40

138.75

u/l

—

Flatulence and related conditions

6.31

2.38

1.0

1.3

91.60

72.63

u/l

—

Diseases of salivary glands

701

1.37

2.35

1.1

100.99

81.88

u/l

0.59

631

Calculus of kidney and ureter

600

1.40

2.35

1.1

83.75

91.63

u/l

0.51

545

Other chronic obstructive pulmonary disease

128

802

1.32

2.35

1.2

1.1

89.50

88.42

u/l

0.06

112

713

Urticaria

600

1.40

2.35

1.2

1.1

91.39

82.20

u/l

0.54

545

Spinal stenosis

161

957

1.28

2.34

1.2

1.1

78.79

87.83

u/l

0.70

142

860

Female genital prolapse

100

410

1.38

2.34

1.1

70.45

82.80

u/l

1.32

371

Respiratory conditions due to other external agents

3.24

2.31

1.4

1.1

65.33

101.86

u/l

—

Umbilical hernia

503

1.43

2.28

1.2

1.1

95.69

89.12

u/l

0.16

454

Abscess of external ear

3.51

2.27

1.1

75.38

98.77

u/l

—

Visual disturbances and blindness

151

1183

1.28

2.27

1.2

1.1

86.53

83.89

u/l

0.11

136

1065

Irregular menses

140

855

1.29

2.26

1.2

1.1

73.02

75.11

u/l

0.23

129

782

Acquired absence of organs, not elsewhere classified

3.93

2.26

1.1

1.2

65.29

96.95

u/l

—

Alcohol use disorder, ICD-based

110

828

1.33

2.23

1.1

107.33

85.17

u/l

0.77

756

Behavioural syndromes associated with physiological disturbances and physical factors

268

1581

1.20

2.23

1.2

1.1

80.37

84.59

u/l

0.35

243

1429

Sulfonylureas

102

602

1.35

2.22

1.1

103.26

85.74

u/l

0.91

529

Autoimmune hepatitis

5.62

2.22

1.0

120.20

94.56

u/l

—

Fracture at wrist and hand level

649

1.37

2.19

1.1

95.91

86.37

u/l

0.29

593

Symptoms and signs involving speech and voice

737

1.35

2.18

1.1

77.52

84.50

u/l

0.57

663

Acute alcohol intoxication, ICD10

328

1.53

2.18

1.1

98.30

92.28

u/l

0.17

306

Asthma (diagnoses ohter than nonallergic)

253

1745

1.20

2.17

1.1

80.53

84.74

u/l

0.49

232

1574

Use of anticholinesterases

617

0.68

2.14

1.0

1.1

94.14

88.61

u/l

0.19

538

N06DA Anticholinesterases

617

0.68

2.14

1.0

1.1

94.14

88.61

u/l

0.19

538

Migraine, single triptan purchase ok & required. ICD-code if available is included

219

1215

1.22

2.14

1.1

78.19

84.09

u/l

0.59

206

1101

Triptan medication for migraine, single purchase ok

219

1215

1.22

2.14

1.1

78.19

84.09

u/l

0.59

206

1101

Phlebitis and thrombophlebitis (not including DVT)

478

1.43

2.11

1.2

1.1

90.10

85.25

u/l

0.15

431

Disorders of adult personality and behaviour

503

1.41

2.11

1.2

1.1

90.47

81.10

u/l

0.21

468

Diseases of male genital organs

117

446

1.32

2.10

1.1

1.2

91.55

96.18

u/l

0.15

106

409

Lymphangioma, anys site

5.06

2.08

1.0

1.2

79.60

82.51

u/l

—

Other hammer toe(s) (acquired)

343

1.48

2.07

1.1

83.07

82.90

u/l

0.01

302

Postmenopausal bleeding

382

1.36

2.06

1.2

1.1

73.27

83.70

u/l

1.05

345

Congenital malformations of gallbladder, bile ducts and liver

4.05

2.04

1.5

1.1

108.43

76.53

u/l

—

Erosion of teeth , including avohilmo

440

1.43

2.04

1.1

84.18

85.46

u/l

0.04

403

Other chronic obstructive pulmonary disease, including avohilmo

155

1020

1.26

2.03

1.2

1.1

89.10

86.47

u/l

0.20

137

914

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

147

1134

1.26

2.02

1.1

78.27

85.15

u/l

0.35

131

1027

Atopic dermatitis, strict definition

497

1.40

2.02

1.2

1.1

74.00

78.56

u/l

0.30

460

Cardiomyopathy

278

1.55

2.02

1.1

86.82

85.21

u/l

0.07

250

Cardiodefibrillation

101

763

1.32

2.01

1.1

89.38

91.16

u/l

0.08

684

Procreative management

557

1.35

2.00

1.2

1.1

75.73

78.45

u/l

0.13

509

Sleep disorders

256

1554

1.19

1.97

1.2

1.1

80.69

85.03

u/l

0.35

232

1405

Schizophrenia or delusion, excluding more controls

522

1.39

1.96

1.2

1.1

73.57

81.34

u/l

0.58

483

Other and unspecified immunodeficiencies with predominantly antibody defects

3.78

1.94

1.2

1.1

112.00

87.69

u/l

—

Other symptoms and signs involving cognitive functions and awareness

135

971

1.27

1.94

1.1

97.07

84.58

u/l

0.53

116

868

Benign neoplasm of eye and adnexa

187

1.66

1.93

1.1

106.76

80.52

u/l

0.76

172

Non-follicular lymphoma

157

1.72

1.92

1.1

104.63

92.08

u/l

0.46

142

Unspecified mental disorder

106

814

1.30

1.92

1.2

1.1

71.40

85.64

u/l

2.00

749

Postmenopausal atrophic vaginitis

382

1.35

1.91

1.1

76.36

82.90

u/l

0.50

343

Other anxiety disorders

114

765

1.29

1.91

1.2

1.1

97.12

77.48

u/l

0.77

106

702

Asthma, including avohilmo

346

1674

1.16

1.90

1.1

78.47

85.20

u/l

1.12

323

1508

Coronary artery bypass grafting

374

1.40

1.90

1.2

1.1

110.78

85.23

u/l

0.69

333

Persistent mood disorders

364

1.46

1.89

1.2

1.1

73.03

87.07

u/l

0.92

332

Stomatitis and related lesions

364

1.46

1.89

1.1

76.97

83.29

u/l

0.31

330

Myocardial infarction, with ST-elevation

299

1.51

1.89

1.0

1.1

92.70

97.12

u/l

0.15

269

Dentofacial anomalies [including malocclusion]

194

1283

1.21

1.89

1.2

1.1

79.94

82.93

u/l

0.22

173

1175

Granuloma annulare

3.21

1.88

1.0

80.86

100.18

u/l

—

Ovarian cyst

105

461

1.32

1.88

1.1

74.23

79.85

u/l

0.50

419

Allergic contact dermatitis due to drugs in contact with skin

2.66

1.87

1.2

1.1

98.12

87.11

u/l

—

Other intervertebral disc disorders

241

1218

1.19

1.84

1.2

1.1

77.67

85.97

u/l

1.01

222

1103

Systemic sclerosis,strict definition

3.57

1.84

1.2

1.1

75.67

58.00

u/l

—

Lifestyle-related condition

3.56

1.84

1.0

1.1

60.00

100.24

u/l

—

Other chondrocalcinosis

4.20

1.83

1.0

1.2

103.80

115.51

u/l

—

Injury of eye and orbit

222

1.58

1.81

1.1

135.30

86.63

u/l

0.66

206

Fall on and from stairs and steps

519

1.37

1.81

1.1

84.53

85.42

u/l

0.05

466

Coxarthrosis, primary, with hip surgery

142

1067

1.25

1.80

1.1

76.28

86.76

u/l

0.87

131

949

COPD, early/later onset

129

862

1.26

1.80

1.2

1.1

89.36

88.52

u/l

0.05

113

771

Kela-code for severe mental illness

720

1.31

1.76

1.1

72.96

85.84

u/l

1.47

662

Superficial injury of abdomen, lower back and pelvis

240

1.54

1.75

1.1

73.29

85.73

u/l

0.75

218

Hyperosmolality and hypernatraemia

3.36

1.75

1.3

1.1

87.33

100.61

u/l

—

COPD related to multimorbidity

111

733

1.28

1.75

1.2

1.1

91.99

89.46

u/l

0.15

651

Malignant neoplasm of stomach, including Hilmo

1.98

1.74

1.1

75.88

89.82

u/l

0.43

COPD, hospital admissions

127

854

1.26

1.74

1.2

1.1

89.85

88.30

u/l

0.09

112

762

Migraine

129

833

1.26

1.74

1.2

1.1

72.23

79.14

u/l

0.94

124

747

Non-Hodgkin lymphoma, all

2.23

1.74

1.1

124.63

96.55

u/l

0.42

Coxarthrosis, primary

179

1252

1.21

1.73

1.1

78.50

88.32

u/l

0.87

162

1116

Background retinopathy and retinal vascular changes

2.68

1.72

1.6

1.1

48.00

102.37

u/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.93

1.72

1.3

1.0

56.43

79.00

u/l

—

Later onset COPD, excluding more controls

306

1.42

1.69

1.2

1.1

91.38

87.60

u/l

0.15

259

Other autoimmune haemolytic anaemias

3.19

1.66

1.2

1.1

120.50

112.58

u/l

—

Retinal detachments and breaks

771

1.29

1.66

1.2

1.1

81.22

83.25

u/l

0.09

688

Other abnormal immunological findings in serum

2.60

1.66

1.1

1.0

101.00

92.32

u/l

—

Other diseases of appendix

2.83

1.65

1.0

1.1

93.79

71.28

u/l

—

Fracture of shoulder and upper arm

772

1.28

1.63

1.2

1.1

99.47

84.94

u/l

0.55

691

Other female pelvic inflammatory diseases

343

1.43

1.63

1.2

64.58

75.37

u/l

0.96

315

Peritonsillar abscess

343

1.43

1.63

1.1

71.85

85.92

u/l

1.09

315

Fracture of skull and facial bones

360

1.42

1.62

1.2

1.1

98.49

80.72

u/l

0.83

331

Use of pramipexole

470

1.36

1.62

1.1

74.37

86.71

u/l

1.01

419

Traction detachment of retina

3.61

1.62

1.0

1.1

83.60

108.15

u/l

—

Thyrotoxicosis with toxic single thyroid nodule

3.61

1.62

1.0

1.1

54.80

56.99

u/l

—

Malignant immunoproliferative diseases

3.61

1.62

1.2

1.1

96.80

115.51

u/l

—

Endometriosis of intestine

3.59

1.62

1.0

1.1

91.20

75.93

u/l

—

Transient ischemic attack

148

979

1.22

1.61

1.1

90.02

83.64

u/l

0.29

132

883

Vasomotor rhinitis (mode)

128

1.72

1.60

1.0

1.1

66.82

82.79

u/l

0.73

119

Enthesopathies of lower limb, excluding foot

480

1.36

1.59

1.2

1.1

97.16

86.60

u/l

0.34

433

Polyarteritis nodosa and related conditions

3.02

1.58

1.2

1.1

91.00

73.90

u/l

—

Cleft lip, lip and palate or palate

3.02

1.58

1.0

1.1

61.00

82.23

u/l

—

Other viral diseases

685

1.29

1.56

1.1

78.27

81.89

u/l

0.21

627

Injury, poisoning and certain other consequences of external causes

149

609

1.23

1.55

1.2

1.1

76.92

80.09

u/l

0.25

138

553

Primary open-angle glaucoma

694

1.28

1.54

1.2

1.1

73.63

87.61

u/l

1.89

618

Mixed conductive and sensorineural hearing loss

224

1.52

1.53

1.1

69.07

84.39

u/l

0.68

199

Hernia

271

1572

1.16

1.51

1.1

89.47

84.58

u/l

0.35

245

1420

Speech and linguistic disorders

1.80

1.51

1.1

79.79

83.20

u/l

0.08

Other factor of the environment

2.88

1.51

1.0

60.00

98.38

u/l

—

Fistulae involving female genital tract

2.87

1.51

1.0

1.2

113.83

77.86

u/l

—

Cardiomyopathy, other and unspecified

108

1.76

1.50

1.0

1.1

86.19

86.71

u/l

0.01

102

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

148

1189

1.21

1.49

1.2

1.1

80.08

81.32

u/l

0.08

139

1075

Disorders of ocular muscles, binocular movement, accommodation and refraction

123

990

1.23

1.48

1.1

74.71

83.77

u/l

0.83

115

898

Other/unspecified dorsalgia

107

849

1.25

1.47

1.2

1.1

77.94

84.25

u/l

0.45

759

Insomnia

244

1532

1.16

1.47

1.2

1.1

80.17

84.91

u/l

0.37

220

1385

Lichen simplex chronicus

2.12

1.44

1.0

1.1

81.09

89.30

u/l

0.18

Vitiligo

3.15

1.44

1.2

1.1

66.40

95.87

u/l

—

Donors of organs and tissues

2.74

1.43

1.2

1.1

104.00

101.16

u/l

—

Oesophagitis

1.92

1.43

1.3

1.2

156.21

88.03

u/l

0.43

Diffuse large B-cell lymphoma

1.98

1.43

1.1

118.46

96.71

u/l

0.43

Diffuse large B-cell lymphoma, helper endpoint

1.98

1.43

1.1

118.46

96.71

u/l

0.43

Diffuse large B-cell lymphoma, including Hilmo

1.98

1.43

1.1

118.46

96.71

u/l

0.43

Herpesviral [herpes simplex] infections

473

1.33

1.42

1.1

92.44

81.09

u/l

0.53

433

Other arthrosis

143

819

1.21

1.40

1.1

83.99

85.74

u/l

0.10

134

737

Diaphragmatic hernia

103

827

1.25

1.40

1.1

78.13

85.93

u/l

0.81

738

Sciatica+with lumbago

145

1109

1.20

1.39

1.1

77.64

86.15

u/l

0.69

134

1005

Disorder of the sleep-wake schedule

2.43

1.39

1.4

1.1

57.14

100.16

u/l

—

Haemorrhage in early pregnancy

616

0.73

1.38

1.1

81.45

75.55

u/l

0.19

571

Excessive, frequent and irregular menstruation

107

469

1.25

1.38

1.2

1.1

67.10

79.86

u/l

2.08

426

Injuries to the shoulder and upper arm

238

1662

1.15

1.37

1.2

1.1

91.05

84.43

u/l

0.40

215

1499

Complications following infusion, transfusion and therapeutic injection

2.63

1.37

1.0

1.1

66.17

104.65

u/l

—

Other prurigo

2.96

1.36

1.0

1.1

99.60

113.09

u/l

—

Phakomatoses, not elsewhere classified

2.96

1.36

1.2

1.1

146.20

98.52

u/l

—

Primary open-angle glaucoma, strict

598

1.29

1.35

1.2

1.1

74.71

86.20

u/l

1.21

531

Ulcer of oesophagus

1.78

1.33

1.2

1.1

81.38

97.39

u/l

0.53

Non-allergic asthma

147

0.47

1.31

1.0

1.1

85.57

84.71

u/l

—

133

Nontoxic multinodular goitre

419

1.34

1.31

1.1

78.02

83.64

u/l

0.41

372

Allergic conjunctivitis

154

1264

1.19

1.31

1.2

1.1

78.92

80.91

u/l

0.14

145

1146

Other nonscarring hair loss

2.80

1.29

1.0

1.3

156.60

83.11

u/l

—

Arthropathy in Crohn disease

2.80

1.29

1.0

1.1

63.00

107.76

u/l

—

Other disorders of choroid

2.79

1.28

1.0

1.1

72.40

95.12

u/l

—

Other enthesopathies

649

1.26

1.28

1.2

1.1

73.86

84.78

u/l

0.61

586

Fourth [trochlear] nerve palsy

2.06

1.27

1.1

106.67

92.30

u/l

—

Papilloedema, unspecified

2.30

1.27

1.3

1.1

138.63

89.00

u/l

—

Fibroblastic disorders

474

1.31

1.26

1.1

83.38

92.10

u/l

0.45

425

Extrapyramidal and movement disorders

103

840

1.23

1.24

1.1

71.90

85.65

u/l

2.05

754

Toxic liver disease

2.41

1.24

1.0

184.67

85.32

u/l

—

Visual disturbances

132

1104

1.20

1.24

1.2

1.1

89.27

84.40

u/l

0.19

117

996

Benign neoplasm: Rectum, anus and anal canal

415

1.33

1.23

1.2

1.1

77.63

86.50

u/l

0.63

374

Open wound of abdomen, lower back and pelvis

2.01

1.23

1.1

81.67

94.73

u/l

—

Injuries to the neck

407

1.33

1.22

1.1

72.76

86.15

u/l

0.90

375

Secondary thrombocytopenia

2.65

1.22

1.2

1.1

64.20

106.06

u/l

—

Family history of other specific disorders

2.65

1.22

1.2

1.1

70.80

90.16

u/l

—

Other viral diseases, not elsewhere classified

457

1.31

1.22

1.1

75.10

84.45

u/l

0.64

419

Secondary polycythaemia

2.17

1.21

1.1

1.2

117.69

86.95

u/l

—

Any dementia

642

0.79

1.21

1.1

85.39

89.77

u/l

0.22

558

Acetic acid derivatives and related substances

290

1.29

1.20

1.1

1.2

97.24

92.13

u/l

0.13

260

Leiomyoma of uterus

191

931

1.16

1.20

1.2

1.1

78.15

79.22

u/l

0.07

173

841

Adenocarcinoma and papilloma adenocarcinoma of rectum

140

1.57

1.19

1.0

1.1

80.68

84.58

u/l

0.11

126

Poisoning by medicine, drug-induced

0.00

1.16

0.0

1.2

—

94.21

—

Alcohol dependence

490

1.29

1.16

1.1

119.22

86.43

u/l

0.66

448

Single spontaneous delivery

523

0.80

1.15

1.1

1.2

66.23

85.32

u/l

2.52

464

Other disorders of veins

118

980

1.20

1.14

1.1

94.92

83.50

u/l

1.16

101

890

Dermatophytosis

160

1371

1.17

1.14

1.1

82.93

u/l

0.00

143

1236

Unspecified/other endometriosis

134

1.57

1.14

1.1

75.65

71.19

u/l

0.17

127

Benign neoplasm: Skin of other and unspecified parts of face

191

1.47

1.13

1.1

62.43

86.53

u/l

2.02

174

Malignant neoplasm of stomach

1.85

1.13

1.1

76.34

92.51

u/l

0.40

Dizziness and giddiness

213

1478

1.14

1.12

1.1

91.19

83.99

u/l

0.42

193

1338

Schizophrenia, schizotypal and delusional disorders

590

1.26

1.12

1.2

1.1

72.71

83.86

u/l

0.96

540

Angina pectoris

151

857

1.17

1.12

1.1

95.53

81.75

u/l

0.64

140

763

Disorders of refraction and accommodation

500

1.28

1.11

1.1

75.79

83.45

u/l

0.36

454

Pregnancy hypertension

112

836

1.20

1.11

1.1

1.2

76.59

74.89

u/l

0.12

106

763

Specific development disorders of speech and language

1.84

1.11

1.2

1.1

87.17

90.15

u/l

0.05

Certain zoonotic bacterial diseases

2.27

1.10

1.0

1.1

87.00

96.97

u/l

—

Ankylosing hyperostosis [Forestier]

2.39

1.09

1.0

1.2

54.80

97.28

u/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.39

1.09

1.0

51.40

99.94

u/l

—

Family history of other conditions

2.39

1.09

1.0

1.1

68.00

106.51

u/l

—

Rotator cuff syndrome

167

1033

1.16

1.08

1.2

1.1

78.63

87.19

u/l

0.85

157

927

Other secondary gonarthrosis

1.69

1.07

1.3

1.1

70.80

77.63

u/l

0.24

Schizophrenia or delusion

585

1.25

1.07

1.2

1.1

73.57

84.06

u/l

0.85

535

Caries of enamel

240

1533

1.13

1.06

1.2

1.1

81.37

84.03

u/l

0.21

216

1396

Benign neoplasm: Sigmoid colon

400

1.30

1.06

1.3

1.1

88.77

89.17

u/l

0.01

363

Other lack of coordination

2.28

1.03

1.2

1.1

44.00

115.55

u/l

—

Transport accidents

114

825

1.19

1.03

1.2

1.1

88.88

78.91

u/l

0.58

102

764

Disorders of optic nerve, not elsewhere classified

2.07

1.03

1.1

50.46

98.65

u/l

—

Complications of other internal prosthetic devices, implants and grafts

1.84

1.03

1.2

1.1

93.55

88.26

u/l

0.10

Combinations of oral blood glucose lowering drugs

572

1.24

1.01

1.0

1.1

85.77

87.68

u/l

0.08

508

Adhesive capsulitis of shoulder

342

1.32

1.01

1.3

1.1

68.42

85.36

u/l

1.91

311

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

125

925

1.18

1.00

1.1

1.2

74.41

76.68

u/l

0.17

118

847

Periapical abscess

1061

0.83

1.00

1.1

94.42

85.62

u/l

0.25

965

Benign neoplasm of brain and other parts of central nervous system

107

1.59

0.99

1.5

1.1

98.66

83.00

u/l

0.21

101

Aortic aneurysm

405

1.28

0.99

1.1

101.64

83.99

u/l

0.71

357

Pregnancy, childbirth and the puerperium

361

0.78

0.99

1.1

1.2

73.58

83.93

u/l

0.66

315

Spondylosis

155

1095

1.15

0.98

1.2

1.1

83.21

87.30

u/l

0.18

131

987

Tularaemia

2.19

0.98

1.0

1.1

101.20

101.30

u/l

—

Other and unspecified haemorrhagic conditions

2.18

0.98

1.6

1.1

107.00

88.91

u/l

—

Vascular dementia (mixed)

2.18

0.98

1.2

1.1

81.20

118.33

u/l

—

Benign neoplasm: Skin of eyelid, including canthus

320

0.69

0.98

1.2

1.1

73.45

85.95

u/l

0.60

288

Toxic effect of alcohol

1.95

0.97

1.3

1.1

223.57

96.53

u/l

—

Post-traumatic wound infection, not elsewhere classified

1.95

0.97

1.0

1.1

110.43

102.38

u/l

—

Other specified/unspecified disorders of bone/cartilage

1.95

0.97

1.0

1.1

64.71

79.39

u/l

—

Glaucoma suspect

100

839

1.19

0.97

1.1

78.39

86.94

u/l

0.76

753

Nontoxic goitre/thyroid nodule

684

1.21

0.97

1.1

73.40

81.32

u/l

0.94

615

Cysts of oral region, not elsewhere classified

1.63

0.97

1.3

1.1

67.09

86.39

u/l

0.71

COPD, hospital admissions 3, with asthma pneumonia sepsis

460

1.25

0.96

1.3

1.1

87.67

91.83

u/l

0.18

412

Right hemicolectomy

100

1.60

0.96

1.3

1.1

132.00

92.22

u/l

0.50

Other disorders of eyelid

127

1036

1.17

0.96

1.1

75.18

87.89

u/l

1.82

113

926

Blepharochalasis

713

1.21

0.95

1.1

71.61

85.32

u/l

1.54

639

Necrosis of pulp, including avohilmo

150

1301

1.15

0.94

1.1

74.20

83.64

u/l

1.47

135

1186

Malignant neoplasm of eye, brain and central nervous system

1.82

0.92

1.3

1.1

113.60

86.25

u/l

—

Unspecified visual impairment (binocular)

2.15

0.91

1.0

1.1

56.67

105.38

u/l

—

Congenital malformations and deformations of the musculoskeletal system

150

1.46

0.90

1.0

1.1

77.23

77.67

u/l

0.01

143

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

101

0.49

0.89

1.2

1.1

98.60

72.91

u/l

—

Asthma/COPD (KELA code 203)

255

1575

1.11

0.88

1.1

73.99

84.09

u/l

2.27

235

1425

Impotence

1.65

0.88

1.0

1.1

156.85

130.63

u/l

0.12

Pleural plaque without asbestos

1.79

0.88

1.2

1.1

126.00

106.67

u/l

—

Congenital malformations and deformations of the musculoskeletal system

119

1.51

0.86

1.1

76.78

81.20

u/l

0.11

113

Preterm labour and delivery

594

1.21

0.86

1.1

74.99

76.27

u/l

0.07

545

Delivery

524

0.84

0.85

1.1

1.2

66.23

85.25

u/l

2.69

465

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

720

1.19

0.84

1.1

78.32

76.94

u/l

0.07

667

Salpingitis and oophoritis

433

1.25

0.84

1.1

1.2

80.55

77.27

u/l

0.15

399

Other benign neoplasms of skin

825

1.18

0.84

1.2

1.1

85.50

84.21

u/l

0.04

736

Hallux valgus (acquired)

565

1.18

0.83

1.1

71.34

85.59

u/l

1.85

506

Maternal care for other known or suspected fetal problems

233

1.28

0.83

1.1

1.2

70.30

75.86

u/l

0.43

223

Disorders of tooth development and eruption

207

1.33

0.83

1.1

65.19

87.58

u/l

2.18

191

Diseases of appendix

197

1588

1.12

0.82

1.2

1.1

77.46

84.40

u/l

1.06

175

1452

Lumbar disc prolapse

172

1169

1.13

0.82

1.2

1.1

79.98

86.32

u/l

0.53

159

1058

Varicose veins

181

1215

1.13

0.82

1.1

82.06

85.01

u/l

0.25

160

1099

Bacterial pneumoniae

720

1.18

0.82

1.2

1.1

76.24

82.87

u/l

0.54

634

Asthma, hospital admissions , main diagnosis only

220

1747

1.11

0.82

1.1

77.29

85.20

u/l

1.12

203

1574

COPD, hospital admission 2, with asthma infections

582

1.19

0.81

1.2

1.1

91.82

91.35

u/l

0.02

518

Dementia

715

0.85

0.81

1.1

76.66

88.08

u/l

1.06

627

Malignant neoplasm of rectum

138

1.45

0.81

1.0

1.1

78.45

83.77

u/l

0.15

124

Asthma and allergy, excluding more controls

153

1.42

0.80

1.3

1.1

92.80

75.43

u/l

0.43

142

Dementia, including avohilmo

765

0.85

0.80

1.1

76.30

87.57

u/l

1.09

670

Other and unspecified tonsillitis

404

1.23

0.79

1.2

1.1

76.19

87.96

u/l

0.61

376

Crushing injury of wrist and hand

0.00

0.79

0.0

1.2

—

111.11

—

Iliotibial band syndrome

0.00

0.79

0.0

1.1

—

88.40

—

Coxibs

295

1.21

0.77

1.1

1.2

89.53

91.35

u/l

0.04

265

Acne

123

1.46

0.77

1.6

1.1

68.78

80.05

u/l

0.60

115

Tonsillectomy and adenotomy

800

0.86

0.76

1.1

75.47

80.49

u/l

0.34

734

Any dementia, excluding more controls

568

0.84

0.75

1.1

80.59

86.74

u/l

0.36

494

Other disorders of thyroid

2.09

0.74

2.0

1.1

43.80

63.54

u/l

—

Hypersomnia

2.09

0.74

1.0

1.1

92.50

115.23

u/l

—

Other mycoses, not elsewhere classified/unspecified

2.01

0.73

1.0

1.1

93.80

88.68

u/l

—

Optic atrophy

2.01

0.73

1.4

1.1

57.00

103.40

u/l

—

Care involving use of rehabilitation procedures

153

1253

1.12

0.72

1.2

1.1

86.50

81.42

u/l

0.40

134

1120

Noninflammatory disorders of female genital tract

108

470

1.15

0.70

1.1

72.85

79.75

u/l

0.65

427

COPD, hospital admissions 1, only main diagnosis

639

1.17

0.70

1.2

1.1

89.14

91.13

u/l

0.10

569

Maternal care related to the fetus and amniotic cavity and possible delivery problems

645

0.86

0.70

1.1

1.2

71.47

74.94

u/l

0.36

595

Meniscus derangement

141

842

1.13

0.70

1.1

83.54

86.28

u/l

0.18

121

758

Appendectomy

168

1443

1.11

0.69

1.2

1.1

76.58

83.85

u/l

1.00

147

1319

Acute alcohol intoxication

454

1.21

0.69

1.1

95.60

86.47

u/l

0.32

417

Abnormal findings in secretions and smears from cervix uteri vagina vulva

105

908

0.87

0.69

1.1

74.80

73.75

u/l

0.08

830

Chronic sinusitis

110

963

1.14

0.68

1.1

77.26

84.14

u/l

0.60

871

Optic atrophy

1.86

0.68

1.4

1.1

57.00

100.63

u/l

—

Propionic acid derivatives

300

1.19

0.67

1.1

1.2

88.01

90.11

u/l

0.08

270

Anti-inflammatory and antirheumatic products, non-steroids

300

1.19

0.67

1.1

1.2

83.49

90.11

u/l

0.29

270

Other intracranial haemorrhages

1.63

0.67

1.7

1.0

66.57

88.53

u/l

—

Asthma and allergy

160

1.36

0.65

1.3

1.1

92.80

75.80

u/l

0.42

148

Carcinoma in situ of skin of trunk

1.59

0.65

1.1

105.43

108.74

u/l

—

Unstable angina pectoris

623

1.15

0.64

1.1

85.24

84.69

u/l

0.03

545

Radial styloid tenosynovitis [de Quervain]

1.48

0.64

1.1

86.20

78.20

u/l

0.27

Other and unspecified nonorganic psychotic disorders

296

1.25

0.63

1.2

1.1

71.21

82.93

u/l

0.71

276

Use of donepezil

376

0.79

0.63

1.0

1.1

82.08

90.18

u/l

0.20

327

Chronic rhinitis, nasopharyngitis and pharyngitis

682

1.16

0.62

1.1

69.09

86.90

u/l

2.90

617

Polypectomy (DHB20)

103

0.58

0.62

1.0

1.1

54.78

93.29

u/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

226

1.28

0.61

1.0

1.1

82.13

77.28

u/l

0.15

217

Pregnancy examination and test

167

0.74

0.60

1.2

1.1

76.25

75.41

u/l

0.03

154

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.60

0.0

1.1

—

79.25

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.60

0.0

1.1

—

76.33

—

Complications of labour and delivery

167

840

1.11

0.60

1.1

70.64

79.53

u/l

1.65

149

762

Ehlers-Danlos syndrome

0.00

0.59

0.0

1.2

—

79.50

—

Malignant neoplasm of mesothelium and soft tissue

1.54

0.59

1.1

153.88

97.28

u/l

—

Multiple delivery

185

0.70

0.58

1.1

1.2

57.04

79.06

u/l

1.28

170

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.48

0.57

1.1

96.88

104.31

u/l

—

Aggressive periodontitis

1.67

0.56

1.3

1.1

77.50

90.42

u/l

—

Soft tissue disorders related to use, overuse and pressure

578

1.16

0.55

1.1

98.55

87.22

u/l

0.26

517

Antepartum haemorrhage, not elsewhere classified

123

0.65

0.54

1.0

1.2

66.25

78.73

u/l

—

118

Appendicitis, broad definition

190

1579

1.09

0.54

1.2

1.1

76.78

84.37

u/l

1.17

168

1444

Melanocytic naevi of scalp and neck

1.54

0.53

1.2

1.1

66.50

108.33

u/l

—

Malignant neoplasm of brain, including Hilmo

1.45

0.53

1.3

1.1

133.11

83.96

u/l

—

Enteropathic arthropathies

1.50

0.51

1.0

69.67

90.54

u/l

—

Other disorders of patella

314

1.21

0.51

1.1

79.00

87.40

u/l

0.47

288

Examination and encounter for administrative purposes

1.41

0.51

1.1

98.78

104.79

u/l

—

Atrophic disorders of skin

287

1.22

0.51

1.0

1.1

87.71

78.14

u/l

0.52

256

Bacterial pneumonia (organism specified)

109

887

1.11

0.51

1.2

1.1

79.72

86.27

u/l

0.54

103

785

Lateral epicondylitis

260

1.23

0.51

1.1

87.52

81.97

u/l

0.10

239

Localized swelling, mass and lump of skin and subcutaneous tissue

678

1.14

0.50

1.1

95.32

84.17

u/l

0.60

608

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

557

1.15

0.49

1.2

1.1

93.98

87.74

u/l

0.13

501

Medical abortion

175

872

1.09

0.49

1.1

81.80

76.80

u/l

0.53

160

786

Unspecified event, undetermined intent

1.49

0.47

1.0

1.1

71.79

97.67

u/l

—

Mumps

1.49

0.47

1.0

1.1

94.40

82.74

u/l

—

Other noninflammatory disorders of vagina

137

1.32

0.47

1.0

1.1

64.83

73.45

u/l

0.56

126

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

154

1119

1.09

0.47

1.1

75.42

80.13

u/l

0.56

140

1017

Atypical facial pain

1.41

0.47

1.2

1.1

70.42

78.83

u/l

0.22

Tinnitus

476

1.16

0.46

1.2

1.1

77.20

85.37

u/l

0.67

425

Acute appendicitis

177

1530

1.08

0.46

1.2

1.1

78.04

84.42

u/l

0.85

156

1399

Lichen planus, including avohilmo

403

1.17

0.45

1.1

75.51

85.04

u/l

0.53

363

Lichen ruber planus, wide definition including periferal and oral lichen planus

488

1.15

0.44

1.1

76.53

83.69

u/l

0.44

441

Foreign body on external eye

211

1.23

0.43

1.3

1.1

75.73

93.61

u/l

1.07

195

Carcinoma in situ of skin of scalp and neck

1.62

0.43

1.0

1.1

138.00

112.50

u/l

—

Pedal cyclist injured in transport accident

415

0.84

0.43

1.2

1.1

101.26

84.01

u/l

0.37

376

Abnormal findings on antenatal screening of mother

0.65

0.42

1.2

51.17

78.28

u/l

—

Tularaemia

1.57

0.42

1.0

1.1

101.20

94.09

u/l

—

Other maternal disorders predominantly related to pregnancy

133

907

0.92

0.41

1.2

1.1

78.50

77.23

u/l

0.08

116

834

Acne vulgaris

1.36

0.41

1.5

1.1

66.23

78.97

u/l

0.61

Melanocytic naevi of eyelid, including canthus

0.00

0.41

0.0

1.1

—

81.26

—

Open bite that required surgery (Lefort1 or BSSO)

0.00

0.41

0.0

1.2

—

99.91

—

Heberden's nodes [with arthropathy]

0.00

0.41

0.0

1.1

—

70.31

—

Frostbite

0.00

0.41

0.0

1.1

—

125.30

—

Benign neoplasm: Scapula and long bones of upper limb

0.00

0.40

0.0

1.1

—

76.24

—

Other injuries of upper limb, level unspecified

0.00

0.40

0.0

1.1

—

123.40

—

Bruxism

1.47

0.40

1.0

1.1

46.40

90.66

u/l

—

Other superficial mycoses

1.47

0.40

1.0

1.1

255.40

85.15

u/l

—

Inguinal hernia

112

819

0.91

0.40

1.1

95.62

88.99

u/l

0.28

734

Subarachnoid haemorrhage

186

1.24

0.40

1.3

1.1

92.61

82.15

u/l

0.19

167

Ehlers-Danlos syndrome

0.00

0.40

0.0

1.2

—

82.94

—

Use of rotigotine

0.00

0.40

0.0

1.1

—

116.78

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.40

0.0

1.0

—

117.04

—

Crowding of teeth, including avohilmo

0.67

0.40

1.1

71.71

78.13

u/l

—

Injury of nerves at lower leg level

0.00

0.39

0.0

1.1

—

117.27

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.1

—

70.27

—

Fasciculation

0.00

0.39

0.0

1.1

—

93.22

—

Use of cabergoline

0.00

0.39

0.0

1.1

—

112.73

—

Complications associated with artificial fertilization

0.00

0.39

0.0

1.1

—

81.32

—

Other congenital malformations of tongue, mouth and pharynx

0.00

0.39

0.0

1.1

—

79.14

—

Ectopic pregnancy

410

0.85

0.38

1.1

78.71

75.21

u/l

0.13

382

Voice disturbances

598

1.12

0.38

1.1

73.69

82.95

u/l

0.76

537

Injury of intra-abdominal organs

1.39

0.38

1.2

1.0

77.26

92.91

u/l

—

Melanocytic naevi of upper limb, including shoulder

1.34

0.33

1.0

1.1

80.80

93.68

u/l

—

Subjective visual disturbances

529

1.12

0.33

1.2

1.1

78.16

84.52

u/l

0.39

476

Vascular dementia (subcortical)

1.31

0.33

1.0

1.1

113.00

117.60

u/l

—

Maternal care for known or suspected abnormality of pelvic organs

318

0.88

0.32

1.2

72.20

76.22

u/l

0.31

304

Disorder of external ear, unspecified

1.32

0.31

1.1

1.2

82.29

92.40

u/l

—

malignant neoplasm of female genital organs

285

1.15

0.30

1.2

1.1

90.22

72.94

u/l

0.93

241

Glaucoma, exfoliation

203

1.18

0.29

1.3

1.1

73.81

88.24

u/l

0.85

182

Gestational diabetes (for exclusion)

490

0.91

0.29

1.1

70.13

74.90

u/l

0.49

459

Acute appendicitis, no complications

134

1251

1.07

0.29

1.2

1.1

78.22

84.19

u/l

0.58

118

1148

Laparoscopic right hemicolectomy

103

1.26

0.28

1.2

1.1

76.62

86.95

u/l

0.22

Mouth breathing

852

1.08

0.28

1.2

1.1

71.06

88.92

u/l

2.97

775

Disturbance of activity and attention

119

1.24

0.27

1.4

1.1

59.42

75.68

u/l

1.05

113

Injury of muscle and tendon at lower leg level

252

1.15

0.27

1.2

1.1

91.42

92.32

u/l

0.02

234

Other noninflammatory disorders of uterus, except cervix

362

1.10

0.26

1.2

1.1

78.75

83.85

u/l

0.27

325

Benign neoplasm of mouth and pharynx

197

1.17

0.25

1.1

78.46

83.38

u/l

0.14

181

Obstructed labour due to maternal pelvic abnormality

362

0.88

0.25

1.2

67.57

79.34

u/l

0.80

328

Other abnormal products of conception

458

1.08

0.25

1.1

74.43

72.84

u/l

0.10

432

Other aneurysm

1.17

0.24

1.7

1.1

137.22

91.26

u/l

—

Primary angle-closure glaucoma

0.70

0.24

1.2

1.1

59.00

80.62

u/l

—

Brain meningioma

0.70

0.24

1.0

1.1

102.17

69.60

u/l

—

Acute appendicitis, with complications

389

1.11

0.23

1.1

77.47

89.15

u/l

0.98

358

Erythema multiforme

1.32

0.23

1.2

1.1

76.60

105.41

u/l

—

Bullous disorders

1.24

0.23

1.0

1.1

79.75

87.18

u/l

0.20

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.22

0.22

1.0

1.1

74.80

72.42

u/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

178

0.84

0.22

1.1

61.40

72.37

u/l

0.80

169

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.1

—

139.41

—

Implicit parasitic Sepsis

0.00

0.21

0.0

1.1

—

83.74

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.2

—

110.89

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.2

—

128.82

—

Accessory breast

0.00

0.21

0.0

1.1

—

83.89

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.1

—

159.62

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.00

0.21

0.0

1.2

—

132.41

—

Lesion of femoral nerve

0.00

0.21

0.0

1.1

—

74.81

—

Other bursitis of elbow

0.00

0.21

0.0

1.4

—

127.18

—

Social disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

81.47

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

1.1

—

44.89

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

1.1

—

50.17

—

Conotruncal defects

0.00

0.21

0.0

1.2

—

72.70

—

Malignant neoplasm of base of tongue

0.00

0.21

0.0

1.3

—

117.09

—

Malignant neoplasm of palate, including Hilmo

0.00

0.21

0.0

1.2

—

96.84

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.21

0.0

1.3

—

96.08

—

Amoebiasis

0.00

0.21

0.0

1.2

—

115.32

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.21

0.0

1.1

—

114.84

—

Unequal limb length (acquired)

0.00

0.21

0.0

1.0

—

127.62

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

64.49

—

Coarctation of the aorta

0.00

0.21

0.0

1.1

—

95.51

—

Gender identity disorders

0.00

0.21

0.0

1.0

—

95.63

—

Other congenital malformations of tongue, mouth and pharynx

0.00

0.21

0.0

1.1

—

54.41

—

Contact with sharp object, undetermined intent

1.16

0.21

1.2

1.1

80.00

93.69

u/l

—

Motorcycle rider injured in noncollision transport accidents

1.16

0.21

1.0

1.2

59.80

94.16

u/l

—

Right side

0.00

0.21

0.0

1.2

—

98.39

—

Hyperprolactinaemia, drug-induced

0.00

0.21

0.0

1.3

—

78.38

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.1

—

60.30

—

Malignant neoplasm of base of tongue, including Hilmo

0.00

0.21

0.0

1.2

—

116.01

—

Other and unspecified pemphigoid

0.00

0.21

0.0

1.2

—

120.92

—

Urticaria due to cold and heat

0.00

0.21

0.0

1.1

—

75.61

—

Unspecified maternal hypertension

0.00

0.21

0.0

1.2

—

102.38

—

Bacterial pneumonia, not elsewhere classified

686

1.07

0.20

1.1

74.95

83.57

u/l

0.73

603

Injury of nerves at ankle and foot level

0.00

0.20

0.0

1.1

—

112.26

—

Cicatricial alopecia [scarring hair loss]

0.00

0.20

0.0

1.1

—

68.56

—

Liposarcoma, including Hilmo

0.00

0.20

0.0

1.1

—

116.29

—

Pedestrian injured in transport accident

114

0.79

0.20

1.1

108.78

82.92

u/l

—

108

Other and unspecified effects of external causes

521

0.92

0.20

1.1

111.17

82.38

u/l

0.87

477

Persons encountering health services in circumstances related to reproduction

128

904

0.95

0.19

1.1

74.25

82.98

u/l

1.10

117

830

Other peripheral vascular diseases

128

1.17

0.18

1.1

75.07

80.11

u/l

0.13

118

Bacterial meningitis

1.21

0.18

1.1

78.24

86.57

u/l

—

Other and unspecified abdominal hernia

1.15

0.17

1.0

1.1

55.43

75.96

u/l

—

Cyst of kidney

110

1.18

0.17

1.1

64.06

92.99

u/l

1.72

101

Alzheimer’s disease (Early onset)

0.75

0.17

1.0

1.1

102.00

93.13

u/l

—

Non-small cell lung cancer, squamous, helper endpoint

0.71

0.16

1.4

1.1

95.20

99.13

u/l

—

Other complications of labour and delivery, not elsewhere classified

120

0.84

0.16

1.2

54.61

76.22

u/l

0.86

114

Other diseases of gallbladder

1.18

0.16

1.3

1.2

98.25

82.20

u/l

—

Redundant prepuce, phimosis and paraphimosis

299

1.09

0.16

1.1

74.35

105.22

u/l

2.28

273

Multiple gestation

151

0.86

0.15

1.2

72.19

78.59

u/l

0.22

146

Vascular syndromes of brain in cerebrovascular disorders

1.14

0.15

1.2

1.1

62.67

93.69

u/l

—

Brain meningioma, including Hilmo

0.80

0.14

1.0

1.1

244.43

70.83

u/l

—

Chronic diseases of tonsils and adenoids

193

1184

1.03

0.14

1.2

1.1

74.17

85.26

u/l

2.08

180

1080

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

103

1.17

0.13

1.3

1.1

92.57

83.00

u/l

—

Other degenerative diseases of the nervous system

420

0.94

0.13

1.1

90.34

80.85

u/l

0.47

377

Oter anti-inflammatory and antirheumatic agents, non-steroids

259

1.07

0.13

1.1

86.36

95.44

u/l

0.35

229

Postpartum haemorrhage due to retained placenta

199

0.90

0.11

1.1

71.91

72.88

u/l

0.03

191

Cervicobrachial syndrome

496

0.95

0.11

1.1

69.74

86.26

u/l

1.67

448

Superficial injury of head

445

1.06

0.11

1.1

91.20

80.65

u/l

0.28

404

Brachial plexus disorders

156

0.90

0.10

1.1

70.12

77.32

u/l

0.27

150

Abrasion of teeth

781

1.04

0.10

1.2

1.1

73.30

83.57

u/l

0.99

710

Diabetes mellitus in pregnancy

386

1.04

0.10

1.2

1.1

81.69

74.87

u/l

0.50

365

Glucosamine medication

126

979

1.03

0.09

1.1

89.52

87.84

u/l

0.08

114

867

Hyperkinetic disorders

133

1.10

0.08

1.4

1.1

59.42

75.47

u/l

1.07

125

Pregnancy with abortive outcome

172

878

1.02

0.08

1.2

1.1

75.38

76.83

u/l

0.14

157

791

Abnormal involuntary movements

234

1.07

0.08

1.2

1.1

78.45

86.49

u/l

0.27

212

Femoral hernia

0.86

0.07

1.2

1.1

82.17

83.88

u/l

—

Endometriosis

454

0.97

0.07

1.1

81.85

80.07

u/l

0.10

413

Dislocation, sprain and strain of joints and ligaments of knee

133

1252

0.98

0.07

1.1

77.72

81.20

u/l

0.37

125

1143

Twin gestation

143

0.91

0.07

1.2

72.19

79.07

u/l

0.24

138

Spontaneous abortion

108

746

0.98

0.07

1.1

86.39

75.96

u/l

1.21

683

Injury of muscle and tendon at shoulder and upper arm level

762

0.97

0.07

1.1

76.74

87.69

u/l

1.00

685

Spermatocele

118

1.10

0.07

1.2

1.1

83.54

109.80

u/l

0.49

108

Organic, including symptomatic, mental disorders

123

857

1.02

0.06

1.1

78.24

88.14

u/l

1.06

104

760

Other menopausal disorders

388

0.97

0.05

1.2

1.1

78.65

80.81

u/l

0.07

352

Radiculopathy

334

0.96

0.05

1.1

86.66

86.53

u/l

0.00

300

Benign neoplasm of ovary

407

1.03

0.04

1.2

1.1

77.90

73.79

u/l

0.17

361

Early lumbar disc prolapse, operated

131

1.07

0.03

1.1

65.24

82.59

u/l

0.88

126

Crushed, pushed or stepped on by crowd or human stampede

102

1.08

0.03

1.0

1.1

75.70

84.33

u/l

0.19

Other spirochaetal diseases

691

0.98

0.02

1.2

1.1

80.51

83.79

u/l

0.19

620

Foreign body entering into or through eye or natural orifice

117

0.94

0.01

1.3

1.1

74.91

86.95

u/l

0.38

111

Divergent concomitant strabismus

123

1.06

0.01

1.2

1.1

63.83

85.46

u/l

1.15

117

Adverse effects, not elsewhere classified

368

0.98

0.01

1.1

99.45

76.29

u/l

0.87

337

Acute nasopharyngitis (common cold)

166

0.96

0.01

1.1

99.97

95.45

u/l

0.10

155

Stenosis and insufficiency of lacrimal passages

183

1.04

0.01

1.2

1.1

72.68

83.97

u/l

0.66

169

Later onset COPD

480

1.01

0.01

1.2

1.1

88.92

90.93

u/l

0.08

421

Contraceptive management

662

1.01

0.00

1.2

1.1

72.88

82.41

u/l

1.01

610

Ocular pain

145

1.03

0.00

1.3

1.1

72.34

79.69

u/l

0.29

139

Additional codes for the location of defect, injury or illness

1.04

0.00

1.0

1.1

182.10

85.13

u/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

124

0.97

0.00

1.2

1.1

108.79

85.82

u/l

0.42

116

Chronic suppurative otitis media

104

0.96

0.00

1.1

190.80

83.61

u/l

—

Spirochaetal infections, other/unspecified

674

0.99

0.00

1.2

1.1

80.00

84.68

u/l

0.28

604

Chronic suppurative otitis media, including avohilmo

123

0.98

0.00

1.1

169.14

81.23

u/l

0.51

112

Lyme disease

673

1.00

0.00

1.2

1.1

80.00

84.85

u/l

0.29

603

Other spirochaetal diseases

677

1.00

0.00

1.2

1.1

80.51

84.52

u/l

0.24

607

Other disorders of eye and adnexa

256

1.02

0.00

1.2

1.1

66.51

77.30

u/l

0.71

235

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.2

—

59.40

—

Other and unspecified atrophic disorders of skin

0.00

0.0

1.1

—

55.63

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

123.53

—

Collapsed vertebra, not elsewhere classified

0.00

0.0

1.2

—

77.67

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.0

1.1

—

57.71

—

Unspecified parasitic disease

0.00

0.0

1.1

—

131.78

—

Other congenital malformations of skull and face bones

0.00

0.0

1.2

—

42.38

—

Malignant neoplasm of renal pelvis

0.00

0.0

1.3

—

156.38

—

Contact with blunt object, undetermined intent

0.00

0.0

1.1

—

126.72

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

39.02

—

Other specified acquired deformities of limbs

0.00

0.0

1.0

—

49.80

—

Defect, injury or illness of neck

0.00

0.0

1.2

—

56.17

—

Other and unspecified parapsoriasis

0.00

0.0

1.2

—

56.00

—

Acne keloid

0.00

0.0

1.2

—

105.45

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.2

—

55.17

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.2

—

88.60

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.0

1.2

—

143.79

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.0

1.1

—

110.45

—

Liposarcoma

0.00

0.0

1.3

—

120.25

—

Endometriosis of fallopian tube

0.00

0.0

1.1

—

84.38

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.0

—

94.08

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.2

—

124.60

—

Frontotemporal dementia

0.00

0.0

1.1

—

135.14

—

Magnesium deficiency

0.00

0.0

1.4

—

56.00

—

Other congenital malformations of nervous system

0.00

0.0

1.1

—

81.89

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.1

—

55.59

—

Other primary thrombocytopenia

0.00

0.0

1.2

—

54.40

—

Other and unspecified injuries of forearm

0.00

0.0

1.1

—

93.14

—

Other and unspecified spinal muscular atrophies

0.00

0.0

1.2

—

143.56

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.0

1.3

—

59.49

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.3

—

43.85

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.0

1.1

—

130.60

—

Toxic effect of other noxious substances eaten as food

0.00

0.0

1.2

—

37.42

—

0.00

-0.00

0.0

1.1

—

97.01

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.2

—

50.02

—

Disorders of adrenal gland, other and/or unspecified

0.00

-0.00

0.0

1.0

—

105.57

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.2

—

112.62

—

Female infertility, uterine origin

0.00

-0.00

0.0

1.0

—

67.67

—

Drowning and submersion while in natural water

0.00

-0.00

0.0

1.2

—

187.17

—

Other congenital malformations, not elsewhere classified

0.00

-0.00

0.0

1.0

—

40.80

—

Reiter disease

0.00

-0.00

0.0

1.1

—

81.30

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

60.71

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.4

—

52.00

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.2

—

57.35

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.2

—

54.40

—

Mucinous and mucinous cystic tumor

0.00

-0.00

0.0

1.3

—

56.29

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

-0.00

0.0

1.2

—

148.00

—

Other and unspecified pemphigus

0.00

-0.00

0.0

1.2

—

122.62

—

Malignant neoplasm of hypopharynx

0.00

-0.00

0.0

1.0

—

193.02

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.2

—

57.50

—

Chromophobe cell carcinoma of kidney

0.00

-0.00

0.0

1.2

—

120.85

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.2

—

109.74

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

133.85

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

51.20

—

Restrictive cardiomyopathy

0.00

-0.00

0.0

1.2

—

111.02

—

Ovarian dysfunction, other/unspecified

0.00

-0.00

0.0

1.2

—

77.78

—

Chondrosarcoma, including Hilmo

0.00

-0.00

0.0

1.2

—

139.02

—

Malignant neoplasm of lip

0.00

-0.00

0.0

1.3

—

116.64

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.1

—

51.57

—

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.4

—

111.82

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

-0.00

0.0

1.2

—

86.34

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.1

—

129.44

—

Separation of retinal layers (serosa)

0.98

-0.00

1.0

1.1

67.42

90.45

u/l

—

Carcinoma in situ of endometrium

0.00

-0.00

0.0

1.2

—

61.21

—

Disorders of pituitary gland, other and/or unspecified

0.00

-0.00

0.0

1.2

—

41.17

—

Hereditary motor and sensory neuropathy

0.00

-0.00

0.0

1.1

—

75.01

—

Cardiomyopathies, Secondary/extrinsic

0.00

-0.00

0.0

1.0

—

131.14

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.0

—

99.97

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

1.0

—

193.02

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.2

—

43.40

—

Blindness or visual impairment, binocular

0.00

-0.00

0.0

1.2

—

64.02

—

Other cestode infections

0.00

-0.00

0.0

1.4

—

52.00

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.2

—

204.60

—

Implicit parasitic Sepsis

0.00

-0.00

0.0

1.0

—

100.59

—

Non-small cell lung cancer, squamous

0.89

-0.00

1.4

1.1

95.20

99.22

u/l

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.2

—

89.18

—

Congenital malformations of pulmonary and tricuspid valves

0.00

-0.00

0.0

1.0

—

93.37

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.2

—

46.42

—

Prominent ears

0.00

-0.00

0.0

1.0

—

51.70

—

Amoebiasis

0.00

-0.00

0.0

1.3

—

108.18

—

Mucinous and mucinous cystic tumor, including Hilmo

0.00

-0.00

0.0

1.2

—

57.67

—

Slow fetal growth and fetal malnutrition

0.00

-0.00

0.0

1.0

—

54.58

—

Rhinophyma

0.00

-0.00

0.0

1.1

—

199.14

—

Congenital varicose veins

0.00

-0.00

0.0

1.2

—

59.67

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.2

—

102.78

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.2

—

179.33

—

Tetralogy of Fallot, a congenital heart defect.

0.00

-0.00

0.0

1.2

—

89.45

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

1.0

—

39.40

—

Other congenital malformations of female genitalia

0.00

-0.00

0.0

1.1

—

63.89

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

40.00

—

Ectopic testis

0.00

-0.00

0.0

1.0

—

37.40

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

1.0

—

97.21

—

Arnold-Chiari syndrome

0.00

-0.00

0.0

1.1

—

81.89

—

Marfan's syndrome

0.00

-0.00

0.0

1.0

—

57.22

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.2

—

55.17

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.0

—

98.62

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.2

—

92.20

—

Hypospadias

0.00

-0.00

0.0

1.0

—

37.40

—

Osteomalacia

0.00

-0.00

0.0

1.0

—

71.14

—

Other congenital malformations of integument

0.00

-0.00

0.0

1.2

—

115.22

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

40.00

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

1.3

—

167.00

—

Undescended testis, unilateral

0.00

-0.00

0.0

1.0

—

70.15

—

Abscess of tendon sheath

0.00

-0.00

0.0

1.1

—

137.09

—

Senility

0.00

-0.00

0.0

1.0

—

166.40

—

Superficial frostbite

0.00

-0.00

0.0

1.1

—

87.31

—

Lichen planopilaris

0.00

-0.00

0.0

1.4

—

53.60

—

Effects of heat and light

0.00

-0.00

0.0

1.2

—

125.52

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

1.1

—

53.00

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

56.70

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

1.3

—

89.33

—

Injury of other and unspecified intrathoracic organs

0.95

-0.00

1.3

1.1

109.21

94.27

u/l

—

Muscular dystrophy

0.00

-0.00

0.0

1.2

—

52.68

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.2

—

56.02

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.0

—

141.13

—

Chylothorax

0.00

-0.00

0.0

1.2

—

35.02

—

Complications following myocardial infarction

0.00

-0.00

0.0

1.2

—

163.20

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.0

—

97.02

—

Hordeolum and other deep inflammation of eyelid

1.00

-0.00

1.4

1.1

79.00

82.48

u/l

—

Contact with hot air and gases

0.00

-0.00

0.0

1.2

—

64.18

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

141.44

—

Transient retinal artery occlusion

0.00

-0.00

0.0

1.4

—

121.20

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.2

—

112.60

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.0

—

60.52

—

Meningitis, viral

0.00

-0.00

0.0

1.1

—

65.86

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.0

—

58.60

—

Lesion of medial popliteal nerve

0.00

-0.00

0.0

1.1

—

91.14

—

Femoral hernia, bilateral

0.00

-0.00

0.0

1.3

—

96.00

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS